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1. 1 Thesis objectives. 
CHAPTER I .  
I NTRODUCTION 
The o bj ectives o f  this thes i s  a r e  
1.  to p rovide a comp r ehens ive g u ide to u s ing Pocock ' s  
g roup s equ ent ial method f o r  c l i n ical t r i als and 
2. to show by compu ter  s imul a tions that the g roup 
sequential method i s  app ropri ate when us ing the logistic 
r eg r es s ion model . 
In s ec tion 1. 2 ,  c l i n ical t r i als a r e  def ined with an 
emphas is on Pha s e  I I I  c l i n ical t r i als . The p r ima ry intent o f  
sec t ions 1. 2 and 1 . 3 i s  t o  desc ribe c l i n ic al t r ial 
cha rac te r i s t ic s  which suggest that inte r im analyses are  
d es i r able. In section 1. 4 ,  it is shown that inte r i m  analyses 
s houl d  not con s i s t  o f  perfo rming the usual s ig n i f icance 
tes ts. Chapter 1 ,  then , des c ribes the bas i s  for the 
d evelopment o f  the g roup s equent i a l  method . 
Chapter 2 desc r i bes the g roup sequent ial method in 
detail ( obj ective 1 1 ) and chapte r 3 incl udes the r esults of 
the Monte C a r l o  s tudy ( obj ective 1 2 ) .  
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1.2  Clinical trials. 
In o rd e r  f o r  a new t r eatment to g ain acceptanc e  by 
cl i n i c i ans , its  s afety and e f f ic acy mus t  be p roven . C l i n ic al 
t r i als s erve this pu rpose . The new t r eatment is 
sys tema t i c al l y  evaluated in fou r phases . The i n i t i a l  
inve s t ig a t ion , . a  P h a s e  I s tudy , p rovides d ata c ol l ected by 
obs e rving t he e ffect of the t reatment on heal thy vo luntee r s  
o r  on patients who a r e  n o t  c andidates fo r convent ional 
the r apy . The o bj e c t ive o f  a Phase I s tudy i s  g ene rally to 
ass e s s  the s af ety and tole rabi l i ty of the t r eatment . F o r  
ex ampl e ,  in s tudying a new d rug , a Phas e I s tudy may be used 
to inves t igate acceptabl e dose l evel s . Addi t ional l y ,  
pharmac olog i c al s tudies to determine abso rption and 
b i oavai l abi l i ty o f  the d rug s hould be impl emented ( Les s e r , 
1 98 3 ) .  The s ampl e  s ize o f  a Phase I s tudy i s  sma l l  in o rder  
to  r educe human expo s u r e  to a new t reatment . 
In Pha s e  I I  s tudies, s ubj ects a r e  patients with 
symptoms o f  t he d i s ease f o r  which the  t reatment i s  
intended . T h e  pu rpos e  o f  these s tudies is to collect fu r ther  
d ata o n  t r eatment e f f i cacy and safety in dis eas ed subj ects 
( Ne is s  and Boyd, 1 98 4 ) . Su f f i c i ent d ata s hould b e  coll ected 
to dete rmine i f  the t r ea tment has a the rapeutic effect which 
wa r rants f u r the r s tudy . 
a 
o f  the new t r eatment to a con t rol t reatment ( eg .  pl ac ebo o r  
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well -acc epted t reatment) . T r eatment compa r i sons may be of the 
follow ing types : 
1 .  a new d rug o r  ther apy vs. a s tanda rd d rug o r  
t he r apy ;  
2 .  a su rg ic al t r eatmen t  vs . a medical t r eatment ;  
3 .  two o r  mo r e  acc epted t r eatments ; 
4.  a d ru g  o r  ther apy vs. pl acebo o r  no t r e atmen t  and 
5. d i f f e r en t  fo rms of the s ame t r eatment. 
I f  t he n ew t reatment i s  found to be mo r e  bene f i c i al than the 
control t reatment ,  a Pha s e  IV s tudy would be c onducted to 
meas u r e  the e f f ec ts of chronic usag e  and to determine new 
uses f o r  t he t reatment ( Smi t h ,  1 9 76 ) . 
The l a r g e s t  body o f  t he s c ient i f ic l i te r atu r e  on c l in ic­
al t r i al s  focuses on Phas e I I I  s tudies ; we w i l l  do l i k ew i s e  
in this pape r. A Phase I I I  s tudy c a n  be def ined a s  a 
randomized , con t r o l l ed c l i n ical t r i al. I t  cons i s ts o f  fou r 
essen t i al s teps ; patient s elect ion , r andomiza tion to t r eat­
ment , t r ea tment pe r i od , and s ta t is t ical analys i s  ( Ju hl , 
1 98 2 ) . Tr i al entry c r i te r i a  a r e  spec i f i ed and only patients 
satisfying these c r i t e r i a  a re s elected. If the c r i te r i a  are  
comp r ehen s iv e , the t rea tment d i f f e r ences may be small  due to 
heterog ene i ty in t he s tudy popu l at i on but resul ts may be mo re 
wid ely app l i c abl e. I f  c r i te r i a  a r e  r es t r i c t ive , the cont r a ry 
may be t r u e ;  that i s , a s ta t i s t i c al d i f f e r ence is  mo r e  l i k ely 
to be found due to homogene i ty in the s tudy popu l ation , but 
the r es u l t s  may not be b r o adly gene ral ized to the population 
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at l a rg e. The r efo r e ,  when cons ider ing the patient population 
to be s tud i ed , one s hould cons ider  the magnitude of the 
t reatment d i f f e r ences expected as well as l i m i ta t i ons on 
gene ral i za t ions o f  r esul ts. After a patient is selected f o r  a 
clin ical t r ial , randomi zat ion i s  perfo rmed to r emove 
sys tematic  b i as in t he all ocation of pati ents to t r eatment 
g r oups and , b as ed on s ampl i ng theo ry , to val idate s tatisti cal 
tests and es t imation p rocedu r es.  Pocock ( 1 97 9 )  des c r ibes 
randomizat ion s chemes appropri ate f o r  c l i n ical t r ials.  It is 
essent ial that one cons ider t he expe r imental des ign of the 
t r i al and the p rognos t i c  va r i ab l es to be cont rolled when 
choos ing a randomi z a t i on scheme . Onc e  r andomi z ed to 
treatment , the t reatment pe r i od beg i ns d u r ing which the 
responses of interest a r e  obse rved. Armi tag e ( 1 9 6 0 )  
clas s i f ies r esponse v a r i ab l es into f o u r  types ; tho s e  r eported 
by the patient , those obse rved by c l i n ical examine r s  o r  by 
use o f  some techn ical appar atus , tho s e  i nvolv ing a c hange in 
medi c al care and l i f e  o r  death. Response data i s  collec ted 
and a s ta t i s t ical analys i s  is c onducted to d etermine if the 
treatments d i ff e r .  
One featu r e  t hat d i s t ingu i s hes c l i n ical t r i als f r om 
o the r expe r imental des igns i s  that s ubjects do not o rd in a r i ly 
enter the t r i al all at once. Typ ically , pati ents ent e r  
sequential ly and , consequently , the leng th o f  patient entry 
may be c ons iderab l e , particul a r ly i f  the inc idence o f  the 
d i s ease be ing s tudied is  low or if the t r ial  is l imi ted to a 
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s ing l e  med i c al cente r . Respons es are then obse rved s e r i ally 
and inve s t ig ato rs may be tempted to do an inter im analys is on 
the data as it accumu l ates . 
1.3 Reasons for doing interim analyses 
Pocock ( 1 9 81 ) has sugges ted f ive poss ible reasons f o r  
doing int e r im analyses o n  accumul ating data : 
1 .  to ins u r e  that the t r ial protocol i s  being 
fol l owed ; 
2. to mon i to r  f o r  adv e r s e  e f fects to t r eatment ; 
3. to c heck f o r  p roblems in data collec t i on ; 
4. to ma intain enthu s i asm f o r  the t r ial  and 
5 .  to look f o r  a s ig n i f i c an t  d i f f e r ence between 
t r eatments which may w a r r an t  s topp ing the t r i al . 
P roper admin i s t r a tion o f  the t r ial s hould solve p roblems 
relat ing to r easons 11 and 13. One would hope that Phase I 
and Phase I I  s tudies woul d  ident i fy t he toxic e ffects o f  the 
t r eatment and t he r e f o r e  el iminate r eason 12. Howeve r ,  s ince 
the patient entry c r i t e r i a  and s ampl e  s i z e  in a Phase I I I  
s tudy may d i f f e r  ma r k edly f rom Phase I and Phase I I  s tudies 
o f  t he t r ea tmen t ,  add i t ional tox i c  effects may be obse rved . 
For  exampl e , t he patient populat i on in a Phase I I  s tudy may 
be mo r e  hete rogenous , and therefo r e ,  tox i c  effects may s how 
up in subg roups of the popu l at ion which we r e  not rep r es ented 
in the e a r l i e r  s tudies . Re ason 12 t hen may be s u f f i c i ent 
r eason for do ing an inte r im analys is with the intent of 
d iscon t inu ing t r eatment or c hang ing the t r eatment p ro tocol to 
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r emove the toxic  ef fects . Re ason t 4  would be particula rly 
r elevant for long-term t r i a ls o r  mu l t i-center t r ials whe r e  
one m i g h t  be tempted t o  satisfy t h e  c u r ious i ty o f  
inves t i g ato r s  b y  p rovid ing info rmation on t h e  p rog ress o f  the 
t r i a l .  Supplyi ng data on t r e atment compa r i sons , howeve r ,  
would mos t  c e r ta inly b i a s  pat ient select ion which in tu rn 
lends unc e r ta inty to the val i d i ty o f  the s t a t i s t ical 
analys is. Add i t ional l y , knowl edg e o f  unexpected results may 
dimi n i s h  enthu s i asm f o r  the t r i al.  Howeve r ,  information 
unrel a ted to r esponse v a r i ab l es , such as the numb e r  of 
pat i ents entered i n  spec i f ied s t r a ta , may be p rov ided which 
may placate t r i a l  pa r t ic i pants w i thout s ac r i f i c ing bl indness . 
The f i f t h  reason i s  val id f rom an ethical as we l l  as an 
economi cal v iewpoin t ,  the f o rme r be ing o f  g reater impo r tance 
in a c l i n i c al t r i al .  Ethically , i t  i s  des i rable to s top the 
use o f  a less  bene f i c i al t rea tment in favor  of a s upe r i o r  
t reatment so a s  t o  d ec rease t h e  numb e r  o f  patients exposed to 
the infe r i o r  t r eatment. Moreove r ,  s topping a t r i al early 
dec reases the ove r a l l  l ength o f  the s tudy and the s ampl e 
s i ze; these two f acto rs s hould be economically attrac t ive to 
suppo r t e r s  of c l in ical t r i al s . 
The r e ason f o r  do ing an inte r im analys i s  s hould be 
clear to the tr i a l  o rg an i z e r s  so that a s topp ing rule may be 
fo rmu l ated. A s topping rule i s  some c r i te r i a  wh ich when 
s at i s f ied d i ctates s topping the c l i n ical t r i al. For exampl e ,  
ac hievement o f  a s ta t i s t ically s ignif icant d i f fe rence between 
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t reatments appea r s  to be the c o r rect c r i te r ion f o r  s topping a 
t r ial.  Yet , in p r ac t ic e ,  due to the compl ex i ty o f  c l i n ical 
t r i al s , o the r f ac to rs bes ides s tatis tical s ig n i f icance mus t  
b e  cons ider ed. Secondary r esponse v a r i ables may be an 
impo r tant facto r ,  and the r e fo r e ,  i t  may be dec ided to 
cont inue the t r ial  in o rder  to collect adequate data fo r 
measu r i ng the e ffects o f  these add i t ional v a r i ab l es. Henc e ,  
tne dec i s ion t o  s top would not b e  made o n  the bas is o f  one 
r esponse var i ab l e. 
Another facto r to cons ider would be the effectiveness o f  
the t reatment s  on s ubg roups o f  t h e  patients in t he s tudy. An 
interest ing exampl e  o f  a c l inical t r i al s topped early due to 
treatment d i f f e r ences in s ubg roups is a s tudy done by the 
Co ronary D rug Proj e c t  G roup ( 1 97 2 )  to meas u r e  the effects o f  
dex tr o thyr o x i ne on t h e  mo rtal i ty r ate o f  co ronary patients. 
The dex t ro thyr o x ine-p l ac ebo d i f f e r ence in ove r a l l  mo r tal i ty 
was not s ig n i f i c an t, b u t  d ex t ro thyrox ine g ene rally man ifes ted 
s ig n i f i c an t ly higher  mo r ta l i ty r ates f o r  s ubg roups o f  the 
data. In r emain ing subg roups , favo r ab l e  ( but not 
statist ically s ig n i f i c an t )  resul ts we r e  obse rved early i n  the 
s tudy b u t  t he t r end was towa rds less f avo rable results as the 
s tudy p rogressed. The s ampl e s i z e  f o r  these sub g roups was 
cons idered to be too small  to war r ent cont inu ing the t r ial. 
The r e f o r e , t he s tudy was d i s continued. Add it ional factors may 
be cons ide r ed in f o rmul at ing a s topping rule depend ing on the 
natu r e  of the c l i n ical t r ial. Whatever c r i te r i a  a r e used , 
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stat i s t i cal r es u l t s  are an in teg ral part o f  the s topp ing rule  
and s hould s e r ve as  an object ive g u ide fo r mak ing dec is ions 
( Pococ k , 1 9 8 1 > . 
The c omplex ity o f  fo rmu lat ing a s topp ing rule  s ho u ld 
not d et e r  c l i n ical t r ial o rgan ize rs f rom o u t l i n ing , a 
p r i o r i ,  the spec i f i c  c r i t e r ia that war ran t stopp ing the 
t r ial . Howeve r , as Poc ock (1 9 7 8 )  and McPhe rson <19 7 4 )  po int 
ou t ,  inte r im analyses are commonly done with no we ll defined 
stopp ing r u l es . A s u r vey o f  4 0  c l i n ical t r ials ( Pococ k , 19 7 8 )  
revealed that 3 3  as sessed inter im res u l ts . All o f  thes e 
t r ials had been in p ro g ress at leas t two years at the t ime o f  
the su rvey . I n  this two year per iod , 2 3  t r ial inves t igato rs 
had loo k ed at the i r  data at leas t 4 t imes , imply ing that 
int e r im analys es are done f r equ ently . Yet 22 of the 3 3  
inves t ig ato r s  had devised n o  fo rmal o r  info rmal s topp ing 
rules . This may suggest that the maj o r i ty o f  inves t igato rs 
we re not look i ng at the i r  data with the in tent of s topp ing 
the t r ial e ven if one t r eatment demons t rated supe r i o r i ty . 
The i r  r eason fo r do ing an inte r im analys is , the r e fo r e , is  o f  
ques t ionab l e val id i ty . S i x  t r ial invest igato rs used repeated 
s ig n i f i canc e  tes t i ng as the i r  s topp ing ru le . As s tated ab ove , 
a s tat i s t ical ly s ig n i f icant t r eatment d i f fe r enc e s hould no t 
cons t i tute a s topp ing rule but is impo rtant in fo rmu lat ing 
the s topp ing rule . F u r the rmo re , the re are p roblems with us ing 
the results of r epeated s ig n i f i cance tes ts . This w i l l  be 
d i scussed in the fol lowing section . 
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1.4 The �roblem with re�eated significance testing .  
Repeated s ig n i f i c ance test ing is defined as the 
pe r iodic p e r fo rmanc e o f  a s tatis t ical  ana lys is on 
accumu l a t ing data to determine if a s ig n i f i c an t  d i ffe renc e 
between t r eatments ex i s ts . Intu it ively one might t h ink that 
as the numb e r  of s ig n i f icance tes ts pe r fo rmed inc reases , one 
wou ld expec t to f ind a s ig n i f icant d i ffe rence pu rely by 
c hanc e .  I n  fac t ,  i f  one p e r f o rms enoug h s ignif icance tests , 
any leve l  o f  nominal s ig n i f i c ance can be achieved eventu ally . 
This phenomenon is refer red to as "s ampl ing to a 
fo reg one conc lus ion" (Co rn f i e ld , 1 9 6 6 ) . Mat hemat ically i t  can 
be s hown to be a cons equ enc e  o f  the law o f  the ite rated 
loga r i thm ( Anscomb e ,  1 9 5 4 ) . 
F o r  exampl e  g iven N ind epend en t and no rma lly 
d i s t r ibu ted r andom var i ab les , X ,X , • • •  ,X with unit va r iance 
1 2 N 
and mean �' the c r it ical r eg ion fo r tes t ing H :p=O vs . H : 
p�O is  
N 
IL X I 
i=l i 
whe re z is  1-a12 
2.-.lN z a , 1- V2 
the uppe r 1-0/2 
0 a 
c r i t ical  po int fo r the 
s tand ard no rma l d i s t r ibut ion . The leve l o f  s ig n i f icance < ) 
for  t h i s  f i x ed sample s i ze tes t is equ al to 
N 
p [ I L X I 2. fN z I ,u=O 1 • 
I f  
i=l i 1-a12 
t h i s  tes t is  done repeated ly ,  the leve l o f  
s ig n i f i c ance inc reas es t o  a l imit o f  one b y  the law o f  the 
1 0  
iter ated log a r i thm wh ich s tates f o r  any K ( Rao , 1 9 7 3 )  that 
n 
P [  I� x. I L K fn inf in itely o ften] = 1 i=1 l 
Since K c an b e  set to any z , any leve l o f  s ig n i f icance 
1 -a1 2 
may b e  r eached with p robab i l i ty one i f  test ing is  done 
extens ively . 
Armitag e ,  McPhe rson and Rowe (1 9 6 9 )  have compu ted the 
exac t p ro b ab i l i t ies of f ind ing a s ig n i f icant d i f f e r ence when 
no d i ffe rence exis ts us ing a method o f  nume r ical integ rat ion . 
G i ven that X , X  , • • •  , X  a r e  r andom va r i ab l es ind epend en t ly 
1 2 N 
d i s t r ibuted N ( p , l ) , the test stat i s t ic for  tes t ing H :p=O vs . 
N o 
H :p�O is  S = 12: X I .  The dens ity funct ion o f  S is defi ned 
a N i=l i N 
recu rs i vely b y  
f ( s ) 
N N 
= f ( u )  
N-1 
0 , otherwise 
-1 2 
< 2 TI> exp[- < s  -u > / 2 1  au , 
N 
-y �s �Y 
N N N 
whe r e  y = z {N with a lpha c hosen as fo r a fixed sample 
N 1 - a;2 
s i ze tes t .  The p robab i l i ty o f  f i nd ing a s ig n i f ican t  
d i f fe r ence when none ex i s ts at o r  befo re N observat ions is P 
N 




= 1 - ) f
N
( u ) du .  
-y 
N 
The r e s u l ts o f  these computat ions are  s hown in Tab le 
1 ,  whic h is  an ab r idged ve rs ion o f  Tab le 2 f rom Armitag e et 
a l . ( 1 9 6 9 ) . The p robab i l i t es in Tab le 1 cle a r ly suppo rt the 
p reviously s tated results o f  the law o f  the it er ated 
1 1  
Table 1. P robab i l i ty o f  detec t ing a s ig n i f i c ant d i ffe renc e 
us ing repeated tests ( N ) at an a s ig n i f icance leve l when the 
nu l l  hypot hes is is  t r u e  and when sampling from a no rmal 
d i s t r ibut ion with known va r i ance • 
a . O S . 0 2 • 0 1  
z l .  9 6 0  2 . 3 3 6  2 . S7 6  
N 
1 o . oso 0 . 0 2 0  0 . 0 1 0  
2 0 . 0 8 3  0 . 0 3 S  0 . 0 1 8  
3 0 . 1 0 7  0 . 0 4 6  0 . 0 2 4  
4 0 . 1 2 6  o. oss 0 . 0 2 9  
s 0 . 1 4 2  0 . 0 6 2  0 . 0 3 3  
1 0  0 . 1 9 3  0 . 0 8 8  0 . 0 4 7  
2 5  0 . 2 6 6  0 . 1 2 6  0 . 0 7 0  
so 0 . 3 2 0  0 . 1 5 6  0 . 0 8 8  
1 0 0  0 . 3 7 4  0 . 1 8 7  0 . 1 0 7  
sao 0 . 4 8 7  0 . 2 S 9  0 . 1 S 2  
1 0 0 0  O . S 3 0  0 . 2 8 8  0 . 1 7 2  
1 2  
log a r i t hm ,  which is  that repeated s ig n i f i c anc e tes t ing 
inflates the alpha level and inc reases the c hanc e of mak ing 
a type I e r ro r .  F o r  example , if a stat i s t i c a l  test is 
repeated fou r t imes ( wh i c h  is  not unc9mmon in c l i n ical  
t r i a ls )  at a leve l  of  s ig n i f icance o f  . O S , the c hanc e of  
mak ing a type I e r r o r  wo u ld be about 2 . S  t imes that leve l  
( 0  . 1 2 6 ) . I t  i s  interes t i "ng t o  note that 1 0  tes ts repeated at 
a nominal s ig n i f i c an c e  leve l of . 0 1 ma intains a t r ue 
s ig n i f icanc e leve l  of app rox imately . O S . 
P robab i l i t ies fo r the b inomi a l  c ase we re lowe r  than the 
no rmal c as e  fo r equ ivalent N ,  wh i c h  Armi tag e et al . (1 9 6 9 )  
expl a in as be ing due to the cons ervativeness o f  the b inomi al 
tes t . For  the exponen t i a l  c as e , p robab i l i t ies we re ve ry c lose 
to tho s e  fo r the no rmal case d i f f e r ing only in the third 
d ec ima l plac e .  
I n  a subsequ ent pape r , McPhe r s on and Armi tag e 
( 1 9 7 1 ) looked at the e ffect o f  r epeated tes t i ng when the null 
hypothes is is  no t t ru e . The s ampl ing d i s t r ibut ion is as 
des c r ib ed f o r  the null cas e . The p robab i l i t ies in Tab le 2 
r e f e r  to the p robab i l i ty o f  c ross ing an upper bound ary which 
is  equ iva l ent to s topping when S � y • The results s how that 
N N 
r epeated test ing inc reas es powe r , wh ich is what we might 
expect due to the r e lat ions hip between the p robab i l i ty o f  a 
type I e r r o r  (Q) and the p robab i l i ty o f  a type I I  e r r o r  <8l. 
That is , as a inc reas es , 8 dec reas es and therefore the powe r 
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Table 2. P robab i l i ty o f  detec t ing a s ig n i f i cant d i f f erence 
us ing repeated tes ts ( N ) at an a s ignif icance level when the 
null hypo thes is is not true and when sampl ing f rom a no rma l 
a 
. 0 5  
. 0 2 
. 0 1 
d i s t r ib u t ion with unit va r i anc e .  
( uppe r bound a r y  only)  
N 
Jl 1 0  2 5  
0 0 . 0 9 7  0 . 1 3 2  
0 . 5  0 . 4 97 0 . 8 1 5  
1 . 0  0 . 9 2 5  0 . 9 98  
1 . 5  0 . 9 9 8  1 . 0 0 0  
0 0 . 0 4 4  0 . 0 6 3  
0 . 5  0 . 3 4 1  0 . 6 9 5  
1 . 0  0 . 8 5 4  0 . 9 9 8  
1 . 5  0 . 9 9 5  1 . 0 0 0  
0 0 . 0 2 4  0 . 0 3 5  
0 . 5  0 . 2 4 7  0 . 5 9 4  
1 . 0  0 . 7 8 4  0 . 9 95 
1 . 5  0 . 9 9 0  l .  0 0 0  
5 0  
0 . 1 6 0  
0 . 9 6 2  
0 . 9 9 8  
1 . 0 0 0  
0 . 0 7 8  
0 . 9 3 3  
1 . 0 0 0  
1 . 0 0 0  
0 . 0 4 4  
0 . 8 9 3  
1 . 0 0 0  
1 . 0 0 0  
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( l -8> inc r eas es . So , even thoug h the powe r o f  detect ing a 
d i f f e r ence is  inc reased by r epeated test ing , i t  is done at 
the expen s e  o f  inc reas ing the p robab i l i ty o f  inc u r r ing a type 
I e r r o r . 
Dec reas ing the r i sk o f  mak ing a type I e r ro r  is  
espec i a l l y  impo rtant in c l in ical t r ials . F o r  example , when 
compar ing a new t r eatment to a s tand ard t r eatmen t ,  falsely 
reject ing H wou ld l ead to the acceptance o f  an · infe r i o r  
0 
treatment b y  t he med ical community and to the reject ion o f  a 
t r eatment onc e cons id e r ed ac c eptab l e . Howeve r , fals e ly 
accept ing H wou ld result  in no c hang e in acceptab l e  med ical 
0 
prac t ic e .  Obviou s l y , the fo rme r e r r o r  is  less des i r ab le . A 
s tat i s t i c al me thod fo r ma intain ing alpha at an acceptab le 
leve l  is  need ed . 
Tab le 1 and Tab l e  2 c l e a r l y  d emons t rate that p-values 
res u l t ing f r om r epeated class ic a l  s ig n i f icance test cannot be 
interp reted in t he usual manne r .  Ins tead , a s topp ing rule  
mus t  b e  fo rmu l ated whic h  cons id ers  the  numb e r  o f  inte r im 
analyses to b e  per fo rmed and the des i red ove ra l l  s ig n i f i c ance 
leve l . The d es ig n o f  the c l i n ical  t r ia l , the r efo re , w i l l  b e  
dete rmined by the s topp ing rule  ( Armitag e , 1 9 6 0 ) . 
CHAPTER I I. 
GROUP SEQUENTIAL METHOD 
2.1 Introduction. 
Whe r eas inte r i m  analyses a r e  j usti f i ed, pa r t icula rly 
f o r  ethical r easons, a s tatis tical met hod which allows 
repeated tes t ing whil e  maintaining an acc eptab l e  ove ral l 
s ig n i f i c an c e  l evel i s  d es i r ab l e. 
I n  the 1 94 0 ' s, Wald ( 1 9 4 7 )  developed the sequent ial 
test whose characte r i s t i c  f eatu r e  i s  that the dec i s ion to 
con t inue test ing i s  b as ed on the outcome o f  observat ions as 
they are made. That is, after  each observation one o f  the 
follow ing three d ec is ions is made: 
1 .  acc ep t  H . I 0 
2 .  r e j ec t  H o r  0 
3. continue the t r ial. 
The s amp l e  s i z e, the refo r e, is  not p redete rmined and, on the 
ave rage, i s  substan t i a lly sma l l e r  than the s ample s i ze for  a 
fixed s ampl e s i z e  des ign. 
Armi tage ( 1 96 0 ) fu r ther devel oped the wo rk of Wald to 
apply s equen t i al met hods to c l in ical t r ials. This methodol ogy 
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requ i r es that pat ients ente r sequent i al ly , in pai r s , and a r e  
randoml y a l l o c ated t o  treatment . The r esponse t ime s hould b e  
s ho r t  r el a t ive t o  the expec ted l eng th o f  patient ac c rual . 
Consequently , as the response t ime inc r eases , the max imum 
number o f  pai r s  ava i l able f o r  analys i s  dec reases while the 
numb e r  o f  pai r s  i n  the t r i a l  i nc r eases . The r efo re , the 
object ive o f  dec reas ing the numb e r  o f  patients exposed to an 
infe r i o r  t r eatment would not be s e rved when the t ime to 
respons e  i s  p ro long ed . 
Ana ly s i s  i s  d one after eve ry pai r  o f  observations , 
the reby r equi r ing a cons tant v ig i l  ove r the accumulat ing 
data . This l a s t  r equi r ement is nec ess a ry so that immed i ate 
ac tion may be taken when a s equen t i a l  boundary is c ros sed , 
whe re c ross ing a bounda r y  is equivalent to r ejec t ing o r  
accep t ing t h e  nul l  hypot hes i s . 
The r e  a r e  some obv ious p robl ems as sociated w i t h  
apply i ng t h e  c l as s i c al ( also refer r ed t o  as fully o r  
cont inuous ) s equen t i a l  method to c l i n ical t r i als . In 
prac t i c e, i t  i s  d i f f icul t  to con t inual ly k eep d ata in the 
proper f o rm f o r  analy s i s . Thi s  is pa r t icula rly d i f f icult in a 
mul t i c ente r t r i al whe r e  admi n i s t ration o f  the t r i a l  i s  
a l ready compl i c ated b y  t he need f o r  ex tens ive d ata mon i to r i ng 
for  qu a l i ty assu rance ( Bendus h et al . ,  1 9 8 4 ) . An add i t ional 
p robl em is that pat ients usually do not enter i n  pai r s and , 
i f  t hey d id , i t  i s  l i kely that they would not be well-matched 
on impo rtant p r ognostic va r i ab l es ( F r i edman et al . ,  1 9 81 ) . 
17 
This p roblem has been add ressed by the deve lopment o f  
sequent i a l  tests wh ich do n o t  requ i r e  that pat ients en ter i n  
pa i r s {Hoe! et a l ,  1 9 7 6 ) . Also , pat ien t  responses are  o ften 
pro long ed . Armitage ( 1 9 6 0 ) s tates that a sequ en t i a l  p rocedu r e  
s ho u ld not b e  cons id ered i f  the t ime t o  response is mo re than 
ha l f  the max imum expec ted leng th of pat ient en t r y .  A 
clas s ic a l  s equent i a l  d es ig n ,  then , wo uld be inapp ropr iate in 
s tudies of t r eatments fo r chron ic d i s eas es ( e . g .  cancer > .  
S ince the s amp l e  s i ze is  d epend ent on the outc omes o f  the 
ob s e r vat i ons , even the mos t  generous t r i a l  spons o r  may feel 
uneasy about the indeterminant leng th o f  the t r i al . Ano the r 
major d i s advant ag e  o f  t he c l ass ical sequ en t i a l  me thod is that 
i t  is  not we l l - r e c e i ved by c l i n ic i ans whose depth o f  
s tat i s t ic a l  knowl edg e does not ex tend b eyond the u s e  and 
interp retat ion o f  the usual s ig n i f i c ance tests ( Poc oc k , 
1 9 8 1 ) . 
An app roach des igned to add ress thes e p roblems 
as soc iat ed w i t h  the c lass ical s equent i a l  me thod is cal led the 
g roup sequen t ial  me thod . Ins tead o f  analyz ing the data after  
eac h pa i r  of  pat ients , s ig n i f icance tests are per fo rmed on 
data accumu l a t ing f r om g roups o f  pat ients ( 2n ,  n pat ients on 
eac h t r e atment )  • The max imum numb e r  o f  tests ( N ) to  be done 
is  p r ed etermined , the r e fo re the max imum leng th of the t r i al 
i s  known . An overa ll s ig n i f icance level < O> is ma intained by 
us ing a mo re s t r ingent nominal s ignif icance leve l < O' >  f o r  
eac h o f  the r epeated s ig n i f i cance tests . 
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2 . 2  Group seQuential design. 
2 . 2 . 1  Gen e r a l  d es c r ipt ion . 
F o r  a g roup sequen t i a l  des ign , pat ien ts a r e  expec ted 
to •nter  sequen t ially and be r andomly a l l ocated us ing a 
pe rmu ted b lock des ig n ,  to one o f  two t r eatments { A  o r  B) , 
such that a f t e r  2n pat ients have en tered the t r i al , the re are  
n pat ients on eac h t r eatment (Poc ock , 1 9 7 7 ) . The response 
var i ab le is. as sumed to be no rma lly d i s t r ibuted with mean , p 
2 A 
and }.l , and common va r i anc e ,  if • F o r  tes t ing the two-s ided 
B 
hypo thes is ; H :}.l -p =0 vs . H :p -p = b ,. the test s tat i s t i .c 
o A B a A B 
at the i th test is  { Pocock , l 9 7 7 ) 
i5 is 
i 
whe r e  
and 
i 
o =� <x - x ) / i ,  i = l ,  • • •  , N  
i j= l Aj Bj 2 
no rma l l y  d i s t r ib uted with mean � and va r i ance � 











1 / i  E(L { X -
j=l Aj 
1 / i  { i�p - i*p 
A B 
Jl - J.l 
A B 
i 
va r (1 / i  � <X 
2 2 ]= 1  Aj 
1 / i  (i { �/ n )  + i 
2 
2 o / in .  
x ) 1 
Bj 
) 
- x ) 1 
2Bj 
< d'  / n ) ] 
The c r i t ic a l  reg ion o f  the l i k e l i hood rat io tes t may be 
expressed as 
- 2 
D /(2d' / { in ) ] .L z ,  i = l ,  • • •  , N .  
i c 
1 9  
2 
Le tt ing Z = D I (26 / ( in ) ] ,  the tes t may be expressed as 
i i 
whe r e  z is  
I Z I L z , i = l ,  • • •  , N ,  
i c 
the c r i t ical  va lue co r respond ing to the 
c 
app rop r i ate s ig n i f icance leve l <a' > . When the above 
relat ions hip is  t r ue , reject H , c la iming a t r eatmen t 
0 
d i f fe r enc e ,  and cons id er s topp ing the c l i n ical t r i a l . When 
the r e lat i ons hip is fals e ,  do not reject H and cont inue the 
0 
t r i a l . I f  Z < z at the Nth tes t , the t r ia l  terminates and a 
N c 
c l a im o f  no t r eatmen t d i f fe r ence is  mad e .  
2 . 2 . 2  Level o f  s ign i f i canc e .  
F rom s ec t ion 1.4 , i t  follows that a nominal level o f  
th 
s ig n i f ic an c e  < a' >  mu s t  be computed so that , at the N tes t , 
the p red etermined ove ra l l  leve l o f  s ig n i f icanc e <a> is  
ma intained . To do so , the max imum numb e r  o f  tes ts ( N ) and the 
d es i r ed ove r a l l  leve l  of s ig n i f icance mus t  be spec i f ied . By 
inve r s e  interpo l a t i on , z and a• may be ob ta ined f rom Tab l e  1 .  
c 
F o r  exampl e ,  f o r  N = 1 0 , the ent r i es o f  interes t < to 5 
dec imal p l ac es ) f rom Tab le 1 a r e  
a . 0 5  . 0 2 . 0 1 
z 1 . 9 6 0 0  2 . 3 26 3  2 . 5 7 5 8  
c 
0 . 1 9 3 3 6  0 . 0 8 7 7 6  0 . 0 4 7 3 8  
To ma intain an a leve l  o f  .05 ' we mus t tes t  at an a• leve l  
b etween . 0 1  and . 0 2 . 
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T o  f i nd a• , d o  the fol lowing interpolat ion : 
. 0 8 7 7 6  - . 0 4 7 3 8  . 0 8 7 7 6  - . 0 5 
= 
2 . 3 2 6 3  - 2 . 5 7 5 8  2 . 3 2 6 3  - z 
c 
whi c h  y i e lds that z = 2 . 5 5 9 6  wh ich is the s tand ard 
c 
no rma l deviate c o r r espond ing to a• = . 0 1 0 6 . Resu lts a r e  given 
in Tab le 3 ( Poc ock , 1 9 77 , Tab le 1 )  fo r N in the r ange 2 to 2 0  
and a = . 0 5 o r  . 0 1 . Note that a s  the numb e r  o f  inte r im 
analys es inc reas es , the nominal s ign i f i cance level < a' > 
dec r eases . 
F o r  exampl e ,  suppose an invest igato r dec ides to 
per fo rm a max imum o f  5 s ta t i s t i cal tests with an ove r a l l  a 
leve l  o f  . 0 5 .  The app rop r i ate z is 2 . 4 1 3  c o r r espond ing to a• 
c th 
o f  . 0 1 5 8 . Then , H i s  r e j ected at the i tes t ,  f o r  i = 
0 
1 ,  • • •  , 5 ,  i f  Z > 2 . 41 3 . Eac h test is r epeated at the s ame 
i 
nominal s ig n i f i c ance leve l . 
The nominal s ig n i f icance leve l is d epend en t on the 
max imum numb e r  of tests ( N) and the o ve ra l l  s ign i f icance 
leve l , not on t he numb e r  o f  p at ients in eac h  group < 2n > . The 
latter f o l lows f rom s ec t ion 1 . 4 ,  whe r e  it was demons trated 
that the p robab i l i ty o f  f ind ing a s ign i f icant d i f fe r ence when 
none ex i s ts (p ) depend s on the numb e r  of obse rvat ions CN> • 
N 
Lik ewise , fo r the group sequent ial method , the ove r a l l  leve l 
o f  s ig n i f icance ac hieved d epends on the numbe r  o f  tests ( N ) 
per fo rmed at an a• leve l . To cont rol a ,  the r e f o r e , the cho ice 
of a• depend s on N .  
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Table 3� Nomi nal s ign i f i c anc e level (Q' ) and cor re spond ing 
no rmal d eviate z r equ i r ed when p e r fo rming r epeated two-s ided 
c 
s ign i f icance tests (N ) I 
Ove r a l l  S ign i f i cance Leve l a = 0 10 5  a= 010 1  
N a• z a• z 
c c 
2 0 10 2 9 4  2�1 7 8  0 10 0 56 217 7 2  
3 0 �0 2 2 1  2 �2 8 9  0 10 0 4 1 2�8 7 3  
4 0 �0 1 8 2  213 6 1  0 10 0 3 3  2�9 3 9  
5 0 �0 1 5 8  2�4 1 3  0�0 0 2 8  2�9 8 6  
6 "  0 �0 1 4 2  2�4 5 3  0�0 0 2 5  3�0 2 3  
7 0 �0 1 3 0  2�4 8 5  0 10 0 2 3  3 �0 5 3  
8 0 �0 1 2 0  2�5 1 2  0 �0 0 2 1  3�0 7 8  
9 0 10 1 1 2  2 15 3 5  0 10 0 1 9  3�0 9 9  
1 0  0 �0 1 0 6  2�5 5 5  0 10 0 1 8  3�1 1 7  
1 1  0 10 1 0 1  2�5 7 2  0 10 0 1 7  3 11 3 3  
1 2  0 10 0 9 7 2�5 8 5  0 10 0 1 6  3 �1 4 7  
1 5  0 �0 0 8 6  2�6 2 6  0 �0 0 1 5  3 �1 8 2  
2 0  0 �0 0 7 5  216 7 2  0 I 0 0 1 3  3 �2 2 4  
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When repeatedly test ing at a constant a' level , i t  is 
th 
possib l e  that the resu l ts of the N test show no sign i f i c ant 
d i ffe rence at the a• level but the f inal p-value is less than 
a. Some stat ist ic i ans (O ' Br ien and F leming , 1 9 7 9 , C anner , 
1 9 7 6  and Peto , l 9 8 1 )  have sugg ested va rying the sign i f icance 
leve l  so that mo re st r ingent levels are  used fo r the in i t i a l  
tests wh i l e  the sig n i f i c ance level fo r the N t h  test wo uld b e  
app roximat ely equ al t o  a. F o r  example , O ' B r i en and F l eming 
(197 9 )  found the following nominal sign i f i c ance levels 
app rop r i ate fo r N-g roup design with a = .OS <a' app rox imated 
f rom O ' B r ien and F l eming , 1 9 7 9 , Tab le 1 > ; 
N 5 4 3 
a' . 0 0 0 1  . 0 0 0 4  . 0 0 0 9  
1 
a' . 0 0 1  . 0 0 4  . 0 1 7  
2 
a' . 0 0 8  . 0 2 0  . 0 4 8  
3 
I . 0 2 3  . 0 4 3  a4 
a' . 0 4 1  
5 
Pocock (1 9 8 1 )  has shown t hat , when H is  t ru e  and 
a 
powe r is  g r eater than . 8 0 ,  these designs requ i r e a larger  
sample s i z e  than a d esign with constant nominal sign i f icance 
leve l .  F o r  example , the 5-g roup va ry ing sign i f i cance level 
d esign shown ab ove , with 1-8= . 9 0 ,  would requ i r e  app roximately 
1 0 %  mo re pat ien ts than the 5-g roup constant sign i ficance 
level d es ig n . Howeve r ,  i f  all f i ve tests are  pe r fo rmed (i . e .  
z < z , fo r i =  1 ,  . • •  , 4 ) , the sample size fo r the fo rme r 
i c 
design w i l l  be 1 5 %  less than the sample s i z e fo r the latter 
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design . Compared to a f ix ed sample size design , the samp le 
si ze f o r  the va rying sign i f i cance le ve l design is 3% larger . 
In f ac t ,  O ' B r i en and F l eming (1 9 7 9 )  have shown that the i r  
me thod is "nea r ly ident ic al" to a f i x ed sample size me thod , 
unl ess the obser ved t r eatment d i f f e r ence is ve ry l a r g e , in 
wh ich c ase e a r ly terminat ion i� possib le . So for sma l l  
t reatment d i f fe r enc es , the r e  appears to b e  l i ttle advantage 
to these d es igns ove r  a f i x ed sample s i z e  design . 
Neve r the less , if the t r eatment d i f f e r enc e is sma l l , O ' Br ien 
and F l eming ' s  met hod may show sign i f i c an t  resu l ts at the Nth 
test wh i l e  Poc oc k ' s  me thod may not . An ex ample given by 
O ' B r i en and F lemi ng (1 979 )  i l lust r ates this point . Howe ve r ,  
it should b e  noted , that the example is somewhat inad equ ate 
fo r compar ing the two methods .  Pocock ' s  met hod r equ i r es gro up 
si zes l a r g e r  t han 10 f o r  a b inary r esponse and app ro xima tely 
equ a l  numb ers o f  pat ients on each t r eatment a rm to ma intain 
prespec i f i ed a and 8 leve ls (Pococ k ,  1 9 7 7 ) . In the example , 
thoug h ,  the g roup s i ze fo r one t r eatment a rm was 7 and the 
g roup s i ze f o r  t he other t r e atment a rm was 1 4 . If the 
treatmen t a rms we r e  of equ i va lent size ( i . e .  both equal to 
1 4 ) , Poc oc k ' s  me thod wou ld also terminate showing sign i f ican t  
resu l t s .  So , O ' B r ien and F l eming ' s  me thod may be useful f o r  
th 
f ind ing impo r tant d i f f e r ences at the N test when samp le 
size is sma l l  and powe r inad equ ate fo r use o f  Pocock ' s  method 
(Pococ k , 1 9 8 2 > . 
F u rthermo r e ,  Poc ock (1 9 8 2 )  has shown , using a 
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nume r ical in teg rat ion minimizat ion p rocedu re , that an opt imum 
design ( i . e .  a d esign with mono ton ically inc reasing 
sig n i f i c ance le ve ls and min imum sample si ze)  is not 
consid e r ab ly d i f ferent from a constant sign i f i c ance level 
d esign w i t h  reasonab le powe r (1 - 8 = . 9  o r  . 9 5 ) . For example , 
a 5-group va r ying sign i f i cance leve l  design , with a= . 0 5 and 
1 -8= . 9 5 ,  a' =  . 0 1 6 5  wh i l e  f o r  the constant level design a· = 
5 
. 0 1 5 8 . Subsequ en t l y , the sample s i ze fo r the two designs a r e  
near ly equ i va l ent . So i f  powe r is ad equ ate f o r  detec t ing an 
impo r tant d i ffe renc e ,  there appea rs to be no advantage to 
varying the sig n i f ic anc e levels . 
2 . 2 . 3  Powe r and sample s i z e . 
Du r ing the d esign phase o f  a c l i n ical t r i al , i t  is 
essent ia l  to do powe r c a lculat ions to asce r t a in the r equ i r ed 
sample s i z e  fo r d etect ing the sma l lest impo r tant c l i n ical  
d i f f e r ence (We iss et a l . ,  1 9 8 3 , Armitag e , l 9 7 9 ,  F r e iman et  al . 
1 9 7 8 )  • Sample si ze requ i r emen ts f rom powe r calculat ions 
sho u ld be compared to the expec ted rate o f  patient acc rual 
and the leng th of t he t r i al to determine the feasib i l i ty of 
the t r i a l . If  an invest ig ato r f inds that the samp le size 
needed fo r d et ec t ing a p r espec i f ied t r eatment d i f fe rence 
c annot be ac hieved , the t r i a l  should be e i ther aband oned o r  
expand ed into a mu l t i c enter t r i a l . 
A su rvey o f  the pub l i shed repo r ts o f  7 1  "neg at ive" 
randomi zed con t r o l led c l i n ical  t r i a ls (i . e .  t r ials whe re the 
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nu l l  hypothesis o f  n o  t r eatment d i ffer ence was not rejec ted )  
showed that the majo r i ty o f  the t r ials lacked su f f i c ien t 
powe r fo r d etec t ing an important c l i n ical  d i ffe rence (F re iman 
et a l . ,  1 9 7 8 )  • An impo rtant c l in ical  d i f ference ( b ) was 
def ined as a 2 5 %  o r  5 0 %  dec rease in response rate f rom the 
con t r o l  r espon s e  r a t e  (b inomial r esponse ) • F o r  b = 2 5 % , 8 0 %  
o f  the t r i a ls had powe r less than . so and only 7 %  had powe r 
g r eater than or equ al to . 8 0 .  F o r  b= 5 0 % , the res u l t s  we re 
somewhat bett e r : 4 4 %  of t he t r i a ls had powe r less than .SO 
and 3 1 %  had powe r g reater than o r  equ al to . 8 0 .  It is 
impossib le to d et e rmine if powe r was inad equ ate bec ause 
s ampl e  s i ze r equ i r emen ts we re not fu l f i l l ed sinc e ,  as F r e iman 
et a l . (1 9 7 8 )  po int ou t ,  few det a i l s  o f  p r i o r  plann ing are  
provided in pub l i shed r eports . Interest ing ly , only 1 t r i al 
r epo r t  s tated the a and 8 leve ls that we re considered befo re 
the s t a r t  of t he t r i a l  and 14 ment ioned that a l a r g e r  samp le 
s i ze was needed . 
I n  a s u rvey (Pococ k , 1 9 7 8 ) , a l r eady r e f e r red to in 
sect ion 1 . 3 ,  3 4  o f  t he 40 t r i al inves t igato rs revealed that 
the r equ i red s ample s i ze was spec i f i ed before b eg inn ing the 
t r i al . On l y  1 8  invest ig ato rs used powe r calculat ions , 8 o f  
wh i c h  based the i r  c alculations on a d i f fe rence o f  1 0 0 %  (no t 
the smallest impo rta.nt d i f fe r ence)  • Howeve r ,  the pat ient 
ac c rual  rates we re not ad equ ate fo r achieving the requ i r ed 
sample s i zes resu l t ing in excessi ve ly p rot rac ted t r i als o r  
inad equ ate powe r . Pocock (1 97 8 )  stated that "unt il a l l  t r i al 
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o rgan i ze rs ob ta in a t ru l y  real istic assessment o f  the 
potent i a l  pat ient acc rual • • •  the p roblem of poo r acc rual 
will  con t inue to ru in a large p ropo r t ion o f  c l i n ical  t r i a ls . " 
The r e fo re ,  the impo r tanc e o f  consid e r ing the results o f  powe r 
calcu l at ions in l ig ht o f  the p rac t ic a l  aspec ts o f  the t r i a l  
( i . e .  t h e  expec ted numb e r  o f  pat ien ts and leng th o f  the 
t r i a l )  s ho u ld no t b e  und e r est imated by t r i a l  invest ig ato rs . 
To d o  powe r c alculat ions , i t  is nec essa r y  to spec i fy 
an ove r a l l  level o f  s ig n i f i c ance <a> , - t he sma l l est c l in ically 
importan t  t r eatment d i f f e r enc e < b> ,  and the p robab i l i ty Cl -8> 
of detec t ing b. F o r  a fixed sample size tes t CN=1 ) , the 
2 
sampl e  s i z e  ( 2n )  i s  computed as follows assuming � is known : 
2 2 




> * 2� I b 
f o r  H IJ - � = b . Simi la r ly ,  fo r a g roup sequen t i a l  
a A B 
d es ig n , t he s i ze o f  the g roups ( 2n )  is d ependent on -the 
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number o f  inte r im analys es ( N) , a ,  8 and 2<1' I . F rom sec t ion 
1 . 4 ,  we s aw t ha t  repeated tes t ing increased powe r as a 
inc r eased . Howeve r , i f  the nominal s ig n i f i c ance leve l is mad e 
mo re s t r ingent with mo re test ing , the powe r dec reases 
( McPhe r son , 1 9 8 2 ) . I t  is necessa ry to f ind 2n suc h  that the 
powe r o f  the t r i a l  is  ma inta ined . Pocock ( 1 9 7 7  and 1 9 8 1 ) uses 
nume r i c a l  in teg rat ion methods to f ind the r equ i r ed va lues o f  
2n . These values are  g i ven i n  Tab le 4 f o r  a =  . 0 5 o r  . 0 1 ,  8 =  
. 7 5 ,  . 9 0 o r  . 9 5 and N f r om 1 to 1 0 . 
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Table 4. Ave rag e  numb er o f  two -sided tests (M ) unt i l  t r i al 
terminat ion and numb e r  of pat ien ts per g roup (2n > requ i r ed 
und er Ha : � -� = [, ,  using va r ious g roup sequ en t ial designs 
A B 2 
fo r r esponses no rma lly d ist r ibu ted with known var i anc e 6 . 
a= 0 . 0 5 
1- B = 0.15 l-8. = o.�o l-8. = 0.�5 
N M' 2n * 'M 2n * M 2n * 
------------- ------------- -------------
1 1 2 7 . 7 5 1 4 2 . 0 4 1 51 . 9 8 
2 1 . 5 8 1 5 . 4 8 1 . 4 1  2 3 . 1 2 1 . 3 1  2 8 . 3 9 
3 2 . 1 9  1 0 . 8 5 1 . 8 8 16 . 1 1 1 . 7 1  1 9 . 7 3 
4 2 . 8 0 8 . 4 0 2 . 3 6  1 2 . 4 3 2 . 1 2  1 5 . 1 9 
5 3 . 41 6 . 8 7 2 . 8 4 1 0 . 1 4  2 . 5 3 1 2 . 3 8-
6 4 . 0 2  5 . 8 3 3 . 3 2  8 . 5 7 2 . 9 4  1 0 . 4 6 
7 4 . 6 3 5 . 0 6 3 . 8 0 7 . 4 4 3 . 3 5 9 . 0 7 
8 5 . 2 4 4 . 4 8 4 . 2 8 6 . 57 3 . 7 7  8 . 0 1  
9 5 . 8 5 4 . 0 2 4 . 7 6 5 . 9 0 4 . 1 8  7 . 1 7  
1 0  6 . 4 6 3 . 6 5 5 . 2 4  5 . 3 5 4 . 5 9 6 . 5 0  
a= 0 . 0 1 
-------------------------------------------------------------
l- 8. = 0.15 l-IJ.= o.�o l-IJ.= 0.�5 
-
N M 2n * M 2n * M 2n * 
------------ ------------- -------------
1 1 4 2 . 2 5 1 5 9 . 5 4 1 7 1 . 2 7 
2 1 . 6 4  2 3 . 1 4 1 . 47 3 2 . 2 4 1 . 3 7  3 8 . 4 2 
3 2 . 3 0 1 6 . 1 0 2 . 0 0 2 2 . 3 2 1 . 8 3 2 6 . 5 2 
4 2 . 9 6 1 2 . 3 9 2 . 5 3  1 7 . 1 4 2 . 2 9 2 0 . 3 4 
5 3 . 6 2 1 0 . 0 .9  3 . 0 6 1 3 . 9 3 2 . 7 5  1 6 . 5 2 
6 4 . 2 7 8 . 5 3 3 . 5 9 1 1 . 7 5 3 . 2 2 1 3 . 9 3 
7 4 . 9 3 7 . 3 9  4 . 1 2  1 0 . 1 8 3 . 6 8  1 2 . 0 4 
8 5 . 5 8 6 . 5 2  4 . 6 5  8 . 9 8 4 . 1 4 1 0 . 6 3  
9 6 . 2 3 5 . 8 5 5 . 1 8 8 . 0 3  4 . 61  9 . 5 0 
1 0  6 . 8 9 5 . 2 9 5 .  7 1  7 . 2 7 5 . 0 7  8 . 6 0  
2 2 
* Mu 1 t ipy eac h ent r y by 6 I [,  . 
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F rom Tab le 4 ,  the max imum sample s i z e may be 
dete rmi ned by 2n * N; th is is the numb er of patients ne ed ed 
i f  one fai l s  to r eject H by the N-1 tes t .  F o r  example , f o r  N 
0 
= S ,  a= . O S and l - 8  = . 9 0 ,  the add itional numb e r  o f  patient 
r esponses 
2 2 
1 0  <5' I b • 
r equ i r ed p r i o r  to eac h test wou ld be app rox imately 
So at the f i rst tes t ,  the samp le s i ze s ho u ld be 
2 2 
approx imate l y  1 0  6 l b  and at the s ec ond tes t ,  
2 2 
s i ze s hould b e  approx imate ly 2 0  a' I � . 
the sample 
Unt i l  tr ial 
te rminat ion , c ontinu e accumu lating data so at the f i fth test . 
2 2 
the max imum samp l e  s i ze o f  S O  a' I� is reac hed . 
An ope rating cha racte r istic cu rve is useful fo r 
meas u r ing the feas ib i l ity o f  a t r ial when an investigato r is 
unce rtain about the expected tr eatment d i ffe r ence but is 
fai r ly c e rtain o f  the expected max imum sample s i ze . In fact , 
F r e iman et a l . ( 1 97 8 )  recommend constr ucting ope rat ing 
c ha racte r istic cu rves b e f o r e  any t r ial is und e rtak en . 
Tab le S ( McPhe r son , 1 9 8 2 , Tab l e  I )  g i ves ope rating 
c ha racte r istics  fo r a f ix ed sample s i ze des ign and fo r 5 
g roup sequential d es igns . The tab le may be g enerali zed fo r 
sample s i zes larg e r  than 8 0  by c omputing K whe re K = 2nNI 8 0 . 
Eac h treatment d i ffe renc e ( scaled by (i6> s ho u ld be d ivid ed 
by {K so that the powe rs in the tab le sti l l  hold . Fo r a g iven 
sample s i ze ,  powe r may be d etermined fo r a range of tr eatment 
d i f fe r ences and fo r a rang e o f  N .  As expected , powe r 
inc reas es with dec reas ing N and with larg e r  tr eatment 
d i f f e r ences . 
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Table 5 I Ope rat ing characte r i s t ics o f  6 g roup sequ en t ial 
des igns w i t h  overall leve l o f  s ignif icance o f  0 . 05 and 
max imum sample s i ze o f  8 0 .  
N 1 2 4 5 8 10 
2n 80 40 20 16  10 8 
a• 0 . 050 0 . 03 0  0 . 01 8  0 . 016 0 . 01 2  0 . 01 1  
o; <f26> 1 - 8 
0 . 1  0 . 09 0 . 08 0 . 08 0 . 07 0 . 07 0 . 07 
0 . 2  0 . 2 4  0 . 2 2 0 . 1 9  0 . 1 9  0 . 1 8  0 . 1 7 
0 . 3  0 . 4 8  0 . 4 3 0 . 3 9  0 . 3 8  0 . 3 6 0 . 3 5 
0 . 4  0 . 7 2  0 . 67 0 . 62 0 . 61 0 . 60 0 . 5 8  
0 . 5  0 . 8 9  0 . 86 0 . 8 2  0 . 8 1 0 . 80 0 . 7 9  
0 . 6 0 . 9 7 0 . 9 5 0 . 9 4 0 . 9 3 0 . 9 3 0 . 9 2 
0 . 8 1 . 00 1 . 00 1 . 00 1 . 00 1 . 00 1 . 00 
1 . 0  1 . 00 1 . 00 1 . 00 1 . 00 1 . 00 1 . 00 
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S ince the most important featu re o f  a g r oup sequ ential 
des ign is  the extent to wh ich it enab les a t r ial to stop 
ear ly ( Pococ k , 1 9 81) , the ave rag e sample s i ze is  o f  g r eate r 
inte rest than the max imum sample s i ze .  The ave rag e sample 
s i ze i s  equal to the p roduct of the ave rag e numb e r  of tests 
requ i r ed when H is true and the g roup s i z e ( 2n ) . Recal l 
a 
that , und er sample s i ze is  depend ent on the 
observations 
H , the 
a 
observed . The r e fo re , the numb e r  o f  tests 
perfo rmed ( M )  i s  a random var iable . G i ven the d istr ibution o f  
M ,  the E [ M ]  may b e  computed . The E [ M ]  i s  the ex pected numb e r  
o f  tests requ i r ed und e r  H (M). I n  othe r wo rds , the M is  the 
a 
numb e r  o f  sig n i f icanc e tests the investigato r w i l l  �robably 
need to do i� o rd e r  to f ind a s ig n i f icant d i ffe rence between 
treatments. Values fo r i are g iven in Tab le 4 ( Pocock , 1 9 7 8 ) . 
The ave rag e  numb e r  o f  patients r equ i r ed fo r a tr ial i s  equal 
to 2nM . Fo r exampl e ,  fo r a 5-g roup d es ign with Q= . Ol and l-8 
2 2 
= . 9 5 ,  the g roup s i ze s ho u ld be 1 6 . 5 2 *d' / b and M wou ld be 
2 . 7 5 . So , on the ave rag e ,  a s ig n i f icant res u lt may be 
expected at the thi rd test . 
As N inc r eas es , 2nM d ec reas es fo r any g iven powe r and 
leve l  o f  s ig n i f icanc e .  The re fore , it seems that f r equ ent 
testing resu lts in expos ing fewe r pat ients to an infe r i o r  
tr eatment . This po int w i l l  be explained fu rthe r in the next 
section . 
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2 . 2 . 4  Cho i c e  o f  N .  
I n  the p r ec ed i ng sec t i ons , we have as sumed that N is 
known .  S ince a• and l - 8 depend on the max imum numb e r  of tests 
to be pe r fo rmed ( N ) , the c ho ic e  of N is  impo rtant . 
F ro m  sec t ions 2 . 2 . 2 and 2 . 2 . 3 ,  i t  may be seen that as 
N inc r eases , mo re s t r ing ent l eve ls o f  a• are r equ i r ed and , 
sub sequ en t l y , to maintain a spec i f i ed powe r , a la rger max imum 
sample s i ze is requ i red . An advantage , ·  thoug h ,  to frequ ent 
tes t ing is a saving s in the ave rag e numb er of pat ients 
need ed . So i f  H i s  t r u e ,  the sample s i ze w i l l  dec reas e with 
a 
inc reas ing N ;  conve rs e l y , i f  H is  true , the sample s i ze w i l l  
0 
inc reas e with inc reas ing N .  F o r  example , compared to the 
numb e r  o f  pat ients requ i r ed in a f i x ed sample s i ze des ign, 
the max imum sample s i ze fo r N = 2 i s  1 0 %  larg e r  wh i l e  the 
ave r ag e  s ampl e  s i z e  is  2 2 %  sma l le r .  Fu rther c ompa r i s ons to a 
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Fo r N > 7 ,  the max imum sample s i ze cont inues to inc reas e 
whi l e  the r e  is no savings in the ave rage · samp l e  s i ze .  So 
the re appear s  to be no advan tag e in do ing mo re than 7 
s ig n i f i canc e  tes ts i f  reduc t ion in total sample s i ze is  the 
p r imary mo t i vat ion fo r us ing a g roup sequent ial me thod . 
The l im i t  fo r N ,  then , may be set at 7 .  The tas k o f  
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choos ing the "b est" N sti ll r emains . In c hoo sing N, an 
investigato r s hou ld cons ider the fol lowing facto r s : 
1 .  the max imum l ength o f  time o f  the tr ial� 
2 .  the ex pected r ate of patient entry� 
3� the t ime lag b etween patient entry and r esponse� 
4 .  p ractical a r rang ements fo r t r ial meet ing s  and 
5 .  uncertainty assoc iated with the tr eatment 
d i f f e r ence estimate . 
The r e l evanc e  o f  the f i r st 4 facto rs to the c ho ic e  o f  N is 
obvious . The l ength o f  the t r ial may be p red ete rmined by the 
ava i lab i l i ty o f  funds o r  by the investigato rs . I nte r im 
analyses then may b e  timed to b e  equ a l l y  spac ed within the 
l imits o f  the l ength o f  the t r i a l . In o rder  to ma intain a 
g iven powe r , ad equ ate numb e r s  o f  patients mu st b e  accumu lated 
b etween tests . With k nowledg e o f  the r ate o f  pat ient entry , 
the g roup s i zes ( 2n )  in Tab l e  4 s e r ve as a g u ide fo r spac ing 
the inte r im analys es . Als o , the length of t ime to response 
must be c ons id e r ed , s ince it is  the numb e r  of pat ient r es u lts 
ava i l ab l e  f o r  analys is that d ictates the actu a l  g roup s i ze . 
The fou rth facto r i s  particu l a r ly r e l evant f o r  mu lticente r 
c l i n ic a l  tr ials whe re it is  neces sary to sched ule t r i a l  
meeting s we l l  in advance . It may be app rop r iate to schedu l e  
inte r im analyses to co inc ide with tr ial meet ing s .  
The f i fth facto r ,  unce rtainty in the estimate o f  the 
tr eatment d i f f e r enc e ,  l ead s to problems in ac c u r ate ly 
d ete rmin ing the max imum sample s i ze requ i r ed for a spec i f i ed 
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powe r to b e  attained . As a cons equ enc e ,  N cannot b e  carefu l l y  
c ho s en . I f  the tr eatment d i f f e r ence is  estimated as the 
s ma l l est c l i n ically impo rtant d i ffe rence and powe r is between 
. 9 0 and . 9 9 ,  the p roblem is not c r it i cal s ince the sample 
s i ze w i l l  b e  ad equate fo r large d i ffe renc es . The p roblem is 
c r itical , thoug h ,  when investigato rs cons id e r  the largest 
plaus ib l e  d i f fe r ence ( McPhe r s on , 1 9 8 2 ) . Unc erta inty 
as soc iated with the latte r ,  the r e fo r e ,  may lead to an 
und e r estimation o f  sample s i ze , mo re f r equ ent testing and 
inc reas ed r i sk o f  not rejecting H when H is fals e .  
0 0 
McPhe r son ( 1 9 8 2 )  tak es a Bayes ian vi ewpo int to 
des c r ib e  the e ffect o f  the unce rtainty assoc iated with the 
tr eatment d i f f e r enc e on the c ho ic e  o f  N .  To i l lustrate th is 
e ff ect , the influence of the p r i o r  d istr ibution o f  the 
treatment d i f f e r enc e estimate on max imum sample s i ze and 
ave rag e samp l e  s i ze is meas u red . I f  the r e  is  a g r eat deal o f  
unc ertainty as soc iated w ith the estimate ( a  d i spe r s e  p r i o r  
d istribution ) , b ut a large treatment e ffect i s  plaus ible , 
f r equ ent testing ( N  f rom 5 to 1 0 )  was found to b e  optimum . I f  
the r e  i s  a strong b i o log ical bas is fo r expecting a tr eatment 
d i f f e r enc e ,  b ut sma l l e r  t r ials have s ho wn no tr eatment 
d i ffe r enc e , a f i x ed sampl e  s i ze test was s hown to b e  optimum . 
I f  the r e  is  a high d eg ree o f  c e rtainty as soc iated with the 
estimate and larg e e ffects are not expected , 2 to 4 tests 
we re found to b e  optimum. These resu lts then may se rve as 
fu rthe r g u id e l i nes fo r c hoos ing N in c onjunction with the 
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fi rst fou r facto rs mentioned . 
2 . 3  Group seQuential analysis . 
2 . 3 . 1  P-values 
Commonly , a stat istical test resu lts in the repo rting 
o f  a p-valu e wh i c h  is the p robab il ity of f inding a tr eatment 
d i f f e r ence as g r�at o r  g r eate r than the one ob se rved if H is  
0 
tru e . F o r  the g roup s equ ential method , at each tes t ,  a p-
value co r r espond ing to z is compared to the nominal 
i 
s ig n i f icanc e l e ve l . I f  s ig n i f icanc e  is  found at the f i r st 
tes t ,  analys is of the r es u lts may b e  treated as i f  f r om a 
fixed samp l e  s i ze test . That is , an investigato r may report 
an exact p-value c o r r espond ing to the Z computed f r om the 
i 
data . Howeve r , f o r  subs equ ent tests , it is  necessary to 
compute an overall p-val u e . I n  othe r wo rds , the p-value 
cor r espond ing to z for i f rom 2 to N s hould not b e  r epo rted . 
i 
Fai rban k s  and Mad s en ( 1 98 2 )  g i ve tab les o f  ove rall p-values 
fo r Q =  . 0 5 o r  . 0 1 and N f rom 1 to 5 , computed by nume r ical 
integ ration . The s e  valu es , fo r Q = . 0 5 , are s hown in Tab l e  6 
( Fai rbanks and Mad s en , 1 9 8 2 ,  Tab les 1 and 3 ab r idged ) . 
F o r  examp l e , suppose an investigato r d ec id ed to do a 
max imum o f  5 tests . At the fou rth test , say Z equal ed 2 . 6 .  
i 
The tr eatment d i f f e renc e ,  then , may b e  repo rted as 
s ig n i f icant at the . 0 4 leve l . 
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Table 6 I P-values fo r a 2-s ided s ig n i f i cance test 
with Q = 0 . 0 5  
A .  When H is rejected 0 
F inal obse rved z 
i 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -N z i 2 . 2  2 . 4  2 . 6  2 . 8  3 . 0  3 . 2  3 I 
c 
1 1 . 9 6 0  1 0 . 0 2 7 8  0 . 0 1 6 4  0 . 0 0 9 4 0 . 0 0 5 2 0 . 0 0 2 6  0 . 0 0 1 4  o . o o  
2 2 . 1 7 8  1 0 . 0 2 7 8  0 . 0 1 6 4  0 . 0 0 9 4 0 . 0 0 5 2 0 . 0 0 2 6  0 . 0 0 1 4  0 . 0 0 
2 0 . 0 4 8 6  0 . 0 3 9 7 0 . 0 3 4 5  0 . 0 3 1 8  0 . 0 3 0 4  0 . 0 2 9 8  0 . 0 2 
3 2 . 2 8 9  1 0 . 0 1 6 4  0 . 0 0 9 4 0 . 0 0 5 2 0 . 0 0 2 6  0 . 0 0 1 4  0 . 00 
2 0 . 0 3 3 2  0 . 0 2 7 8  0 . 0 2 4 8 0 . 0 2 3 3  0 . 0 2 2 5  0 . 02 
3 0 . 0 4 6 0  0 . 0 4 1 6  0 . 0 3 9 5 0 . 0 3 8 5  0 . 0 3 8 1  0 . 03 
4 2 . 3 6 1  1 0 . 0 6 4 1  0 . 0 0 9 4 0 . 0 0 5 2  0 . 0 0 2 6  0 . 0 0 1 4  0 . 0 0  
2 0 . 0 2 9 9  0 . 0 2 4 2  0 . 0 2 1 1  0 . 0 1 9 5  0 . 0 1 8 7 0 . 0 1  
3 0 . 0 4 0 4  0 . 0 3 5 7 0 . 0 3 3 3  0 . 0 3 2 2 0 . 0 3 1 7  0 . 0 3  
4 0 . 0 4 8 8  0 . 0 4 4 7  0 . 0 4 2 9  0 . 0 4 2 1  0 . 0 4 1 8  0 . 0 4  
5 2 . 4 1 3  1 0 . 0 0 9 4 0 . 0 0 5 2 0 . 0 0 2 6  0 . 0 0 1 4  0 . 0 0 
2 0 . 0 2 2 1  0 . 0 1 8 9  0 . 0 1 7 2  0 . 0 1 6 3  0 . 0 1  
3 0 . 0 3 1 9  0 . 0 2 9 4  0 . 0 2 8 2  0 . 0 2 7 7  0 . 0 2 
4 0 . 0 3 9 8  0 . 0 3 7 8  0 . 0 3 6 9  0 . 0 3 6 6  0 . 0 3  
5 0 . 0 4 6 4  0 . 0 4 4 7  0 . 0 4 4 1  0 . 0 4 3 8  0 . 0 4 
B .  When H is  acc epted . 0 z N 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - ·  
N 1 . 0  1 . 4  1 . 6 1 . 8  2 . 0  2 . 2  2 I ' 
1 0 . 3 1 7 4  0 . 1 6 1 6  0 . 1 0 9 6 0 . 0 7 1 8  
2 0 . 3 2 1 4  0 . 1 7 0 3  0 . 1 2 1 3  0 . 0 8 6 7  0 . 0 6 3 4  
3 0 . 3 2 3 6  0 . 1 7 3 2  0 . 1 2 4 6  0 . 0 9 0 6  0 . 0 6 8 1  0 . 0 5 4 1  
4 0 . 3 2 5 1  0 . 1 7 4 9  0 . 1 2 6 5  0 . 0 9 26 0 . 0 7 0 2  0 . 0 5 6 5  
5 0 . 3 2 6 2  0 . 1 7 6 2  0 . 1 2 7 7  0 . 0 9 3 8  0 .  0 7 1 5  0 . 0 5 7 9  0 .  0 5 (  
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2 . 3 . 2  Confid ence inte rvals . 
The observed tr eatment d i ffe rence is an estimate o f  
the t ru e  t r eatment d i f f e r ence . I t  is  usefu l , the r efo r e , to 
cons t r u c t  a c on f idence inte r val to obtain an ind icat ion o f  
the prec i s ion o f  the estimate . The probab i l ity that the 
con f i d en c e  i n t e r val c ontains the true t r eatment d i ffe r ence is 
spec i f ied as 1 - Q. Restated , if sampl ing we re pe r fo rmed 
con t inuou s l y , ( 1 -Q) l OO% o f  the inter vals computed would 
contain the t ru e  t r eatment d i ffe renc e .  
th 
The l imits fo r the conf idence inte rval at the i test 
may be computed as f o l lows ( Jenn ison and Tu rnb u l l , 1 9 8 4 ) : 
lowe r l imit = i5 [ -.1261 {(in)  l z 
i c 
upper l imit = D + [ T261 {(in)  l z 
i c 
whe r e  z i s  the c r itical value c o r r espond ing to a· fo r a N-
c 
g roup s equen t ia l  analys is . Re fer  to Tab le 3 to f ind the 
cor rect  z 
c 
fo r a 9 5 %  <a= . 0 5 )  o r  9 9 %  (Q= . Ol ) confid enc e 
inte r va l . F o r  example , fo r a 5-g roup sequ ential analys is , the 
appropr iate 
2 . 9 8 6  f o r  
z 
c 
i s  2 . 4 1 3  fo r a 9 5 %  con f id ence 
a 99% con f id ence inte r val . F o r  a 9 0 %  
interval o r  
con f idence 
inte r va l , use z f ro m  the fol lowing tab le ( Jenn ison and 
c 










1 0  
z 
c 
1 .  876 
1 .  9 93 
2 . 068 
2 . 1 2 2  
2 . 164 
2 . 1 9 8  
2 . 2 26 
2 . 2 4 5  
2 . 2 7 0 . 
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2 . 4  One-sided grou� seguential method. 
I f  a d i rectional d i f ference is expected , a one-s ided 
test may b e  app rop r iate , s ince it is mo re powe r fu l  than a 2-
s id ed test . Howeve r , power is  less than a fo r a d i ffe r ence in 
the unex pec ted d i rection; that is , one is  pen a l i zed fo r 
ask ing the w rong qu estion ( Hays , 1 9 6 3 ) . S ince c l in ical t r i als 
may reveal r esu lts wh ich are the reve r se of what was 
expec ted , per haps Armitage ( 1 96 0 )  is c o r r ect in stating that 
" one-s id ed s ig n i f i c ant tests are  inapp rop r i ate , in mos t ,  i f  
not a l l , med i c a l  t r i a ls . "  Ethic s ,  howeve r , may p r eclude do ing 
a two�s ided test when compar ing a standard treatment to a new 
treatment ( Demets and Wa re , 1 9 8 0 ) . Continu ing a t r i a l  to f ind 
a new treatment infe r i o r  to a stand ard treatment may 
unneces s a r i l y  expose pat ients to the infe r i o r  treatment . A 
one-s id ed test wou ld allow t r i a l  termination when the 
t r ea tments we re found to b e  equ ivalent o r  the new treatment 
was found to be b ette r than the stand ard treatment . 
Add i t iona l l y , i f  an inves t ig ato r is  c e rta in o f  a d i r ectional 
d i f f e r en c e  and i s  only inter ested in testing the s ig n i f icance 
of t h i s  d i ffe r enc e ,  the choice of a one-s ided test is 
c o r rec t .  But ,  if the new tr eatment has s ome unattr acti ve 
qu al ities ( e . g .  expens ive , pos s ib l e tox i c e ffects , d i f f i c u lt 
to admin iste r >  and the stand ard treatment is reasonab ly 
e f fective , a c on s e r vative test ( i . e .  two-s id ed test) may be 
mo re app rop r i ate . The cho ice of a one-s ided or a two -s ided 
test , the r e fo r e , d epends on the investigato r ' s  depth o f  
3 8  
knowl edg e o f  the t r eatments under  study . 
Demets and Ware ( 1 9 8 0 ) mod i f ied Pocock ' s  two-s ided 
g roup s equential method to a one-s id ed method f o r  testing H : 
0 
}J > Jl . At the ith tes t ,  reject H i f  z > z and acc ept Ho 
A B 0 i c 
i f  z < - z  . The c r it ical values , computed fol lowing the 
i c 
methods o f  A rmitage et al . ( 1 9 6 9 )  ' are g i ven fo r N f r om 2 to 
1 0  in Tab l e  7 ( Demets and Wa re , 1 9 8 0 ) . As expected , the 
nominal s ig n i f icance le ve ls f o r  the · one-s ided test ( Tab le 7 )  
are less str ingent than the c o r r espond ing nominal 
s ig n i f i cance l eve ls f o r  the two-s id ed test ( Tab le 3 ) . 
With a one-s id ed tes t ,  a trial may be te rmi nated with 
acc eptanc e  of H • Howeve r , f r om Tab le 8 ( Demets and Ware , 
0 
1 9 8 0 ) , M und er H is  approx imate ly equal to N ;  the r e fo r e , the 
0 
savings in patients expos ed to the infe r i o r  tr eatment is 
min ima l . F o r  exampl e ,  with N=4 , l -8= . 9 0 and 01 = . 0 5 ,  the 
2 2 
ave rag e 
max imum 
2 2 
2 cr 1 & 
sample s i ze under  H i s  3 . 8 1 * 1 0 . 2 9 6 1 &  and the 
0 2 2 
sample s i ze is  4 * 1 0 . 2 9 � 1 & , a d i f fe rence o f  about 
pati ents . 
Compar ed to the two-s id ed test ( Tab l e  4 ) , the one­
s id ed test affo rds an apprec iab l e  savings in max imum sample 
s i ze . F o r  a des ign with N=7 , l -8= . 9 0 and 0 = . 0 5 ,  the max imum 
2 2 
sample s i ze 
2 2 
4 3 . 3 3 <S I & 
( 2n N )  fo r the two-s ided test is  5 2 . 0 8 CJ 1 &  vs . 
fo r the one-s ided test .  The ave rag e sample s i zes , 
2 2 2 2 
f o r  the d es igns above , are 2 8 . 27 6" I & and 2 2 . 41 6'" I & , 
r espective ly , also impo rtant saving s in sample s i ze .  The 
3 9  
Table 7. Nominal s ig n i f i canc e  leve l � ·  and cor respond ing 
no rma l  deviate z requ i r ed when per fo rming repeated one-s ided 
c 
s ig n i f icanc e tes ts ( N) , 
Q l  = 0 . 0 5  ex • = 0 . 0 1 
- - - - - - - - - - - -- - - - - -- - - -- - - - - - - --
N ot. •  z ex •  z 
c c 
2 0 . 0 3 0 6  1 .  8 7 6  0 . 0 0 5 7 2 . 5 3 2  
3 0 . 0 2 3 2  1 .  9 9 3  0 . 0 0 4 2  2 . 6 3 7  
4 0 . 0 1 9 3  2 . 0 6 8  0 . 0 0 3 4  2 . 7 0 5 
5 0 . 0 1 6 9  2 . 1 2 2  0 . 0 0 3 0  2 . 7 5 4 
6 0 . 0 1 5 2  2 . 1 6 4  0 . 0 0 2 6  2 . 7 9 3  
7 0 . 0 1 4 0  2 . 1 9 8 0 . 0 0 2 4  2 . 8 2 3  
8 0 . 0 1 3 0  2 . 2 2 6  0 . 0 0 2 2  2 . 8 4 8  
9 0 . 0 1 2 4  2 . 2 4 5  0 . 0 0 2 1 2 . 8 7 0  
1 0  0 . 0 1 1 6  2 . 27 0  0 . 0 0 2 0  2 . 8 8 9  
4 0  
Table 8 .  A v e r a g e  n u mb e r  o f  o n e - s i d ed t e s t s  ( M )  u n t i l  t r i a l  
t e r m i n a t i o n  and n u mb e r  o f  p a t i e n t s  p e r  g r o u p ( 2 n )  u s i � g  
va r i o u s g r o u p  s eq u en t i a l  d es i g ns f o r  r e s po n s es n o r m a l l y  
2 
d i s t r i b u t ed w i t h  k no wn v a r i a n c e  o .  
0'- = 0 . 0 5  
Under H Under H 
N M 
2 l .  9 4  
3 2 . 8 8 
4 3 . 8 1 
5 4 . 7 5 
6 5 . 6 8  
7 6 . 6 1  
8 7 . 5 4 
9 8 . 4 7 
1 0  9 . 4 0 
Under H 
N 
2 l .  9 9  
3 2 . 9 8 
4 3 . 9 6 
5 4 . 9 5 
6 5 . 9 4 
7 6 . 9 3 
8 7 . 9 1 
9 8 . 9 0 
1 0  9 . 8 9 
Q � 
l - 8 =  0 . 8 0 
-
M 
l .  5 1  
2 . 0 5 
2 . 5 9 
3 . 1 4 
3 . 6 8  
4 . 2 2  
4 .  7 7  
5 . 3 1 
5 . 8 5 
2 n  * 
1 3 . 8 7 
9 . 7 6 
7 . 5 7 
6 . 2 0  
5 . 2 6 
4 . 5 8 
4 . 0 6  
3 . 6 4  
3 . 3 1 
1 - 8 =  0 . 8 0 
l .  5 7  
2 . 1 7  
2 . 7 8 
3 . 3 8  
3 . 9 8 
4 . 5 8 
5 . 1 8  
5 .  7 9 
6 . 3 9  
2 n  * 
2 2 . 0 7  
1 5 . 3 7 
1 1 . 8 5 
9 .  6 6  
8 . 1 7  
7 . 0 9  
6 . 2 5 
5 . 6 1  
5 . 0 8  
1 - 8  = 0 . 9 0 
-
M 
l .  3 8  
1 . 8 2 
2 . 2 7 
2 . 7 2 
3 . 1 7 
3 . 6 2  
4 . 0 7 
4 . 5 2  
4 . 9 7 
2 n  * 
1 9 . 0 1 
1 3 . 3 1 
1 0 . 2 9 
8 . 4 2  
7 . 1 3 
6 . 1 9 
5 . 4 8 
4 . 9 2 
4 . 4 6 
cf.. = 0 . 0 1 
Under H 
1 - 8 =  0 . 9 0 
M 
l .  4 5  
1 .  9 5  
2 . 4 6 
2 . 9 7 
3 . 4 8 
4 . 0 0  
4 . 5 0 
5 . 0 1  
5 . 5 3 
2 n  * 
2 8 . 3 9  
1 9 . 7 1 
1 5 . 1 6 
1 2 . 3 3 
1 0 . 4 2 
9 . 0 2 
7 .  9 6  
7 . 1 3  
6 . 4 6 
2 2 
* mu l t i p l y  e a c h  en t r y  b y  o" I b 
1 - 8 ;;:: 0 . 9 5 
1 .  2 9  
l .  6 5  
2 . 0 3  
2 . 4 1  
2 . 7 9 
3 . 1 8  
3 . 5 6 
3 . 9 4 
4 . 3 3  
2 n  * 
2 3 . 8 5 
1 6 . 6 5  
1 2 . 8 5 
1 0 . 4 8 
8 . 8 8 
7 . 7 1  
6 .  8 1  
6 . 1 1  
5 . 5 4 
1 - 8 = 0 . 9 5 
-
M 
l .  3 5  
l .  7 8  
2 . 2 2 
2 . 6 6  
3 . 1 1  
3 . 5 5 
4 . 0 0 
4 . 4 4  
4 . 8 8  
2 n  * 
3 4 . 2 0 
2 3 . 6 8  
1 8 . 1 8  
1 4 . 7 9  
1 2 . 4 8 
1 0 . 8 0 
9 . 5 2 
8 . 5 4 
7 .  7 3  
max imum and ave rag e sample s i zes fo r a one-s ided 
sequ ential d es ig n are cons istently sma l l e r  than 
4 1  
g roup 
the 
comparab l e  two-s ided g roup sequential des ig ns . The refo re , 
when c o r rectly c hosen , a one-s id ed g roup s equ ential method is 
advantag eous if the p r ima r y  ob j ective is to d ec r ease the 
numb e r  o f  patients exposed to an infe r i o r  tr eatment . 
2 . 5  Generalization of the group se�uential method. 
Pocock ( 1 9 7 7 )  has s hown that the g roup sequential 
method is  approp r iate fo r c l in ical t r ials with des ign 
c ha racte r istics  vary ing f r om tho s e  d es c r ib ed he re . For tr ials 
with mo re than two tr eatments , a s eparate g roup sequ ential 
des ign fo r eac h treatment compar ison or a g l obal s ig n i f icance 
test is  recommend ed . 
I f  d ata analys is is  s c heduled at equally spac ed time 
inte r va ls , the s i ze o f  the g roup is  l i k ely to var y .  A 
s imu lat i on study s howed that the latte r had essent ial l y  no 
e f f ect on estimates of � and 8 when us ing a g roup sequential 
method . S im i la r  results we re s hown when stratifying , thoug h 
s ome loss o f  powe r was evident when the r e  we re unequal 
treatment numb e r s  within strata . 
Pocock ( 1 9 7 7 )  has also s ho wn that the same nominal 
s ig n i f ican c e  leve ls ho ld fo r a wid e var iety o f  r espons e 
var iab les . That is , by s imu lation , estimates o f  � and 8 we re 
found to b e  ve ry close to requ i r ed leve ls . 
Fo r a no rmal respons e with unknown var ianc e ,  the t r ial 
42 
terminates at the i th tes t  i f  t > t Bas ed on 
i 2 ( in-l l , or. ' 
5 0 0 0  s imu lat ions , a min ima l loss o f  powe r was obs e r ved when 
apply ing g roup s equen t i a l  des igns fo r t-tests ( Poc ock , 1 9 7 7 ) . 
To compare two exponent ial means , A and A , a g roup 
A B 
sequen t i a l  F test wi th � ·  as in Tab le 3 was found to b e  
app rop r iate ( Pococ k , 1 9 7 7 ) . S imu lat ions s howed that es timates 
o f  the t r u e  o ve r a l l  s ig n i f i c ance we re c lose to the requ i r ed 
�. Also , powe r was ma inta ined when us ing sample s i zes 
computed us ing Tab l e  4 and mu l t iplying each en t r y  b y  
- 2  
[ ln < A  I A > l 
A B 
A no rma l app rox imat ion o f  the Wi lcoxon test was also 
found to b e  app rop riate fo r a g roup sequen t i a l  des ign 
( Pococ k , 1 9 7 7 ) . Cons id e r  t r i a l  te rminat ion at t he ith tes t 
i f  { I R - [ in ( 2 in+l ) l / 2 }  
A 
in � [ ( in/ 6 ) + ( 1/ 1 2 ) ] 
> z 
c ' 
whe r e  R i s  the sum o f  the r anks fo r t reatment A .  
A 
F o r  a b in a r y  r espons e ,  the re was no loss o f  powe r ,  fo r 
N � 5 and n L 1 0 .  The tes t stat is tic , at the i t h  tes t , is  the 
following : {:2 [ R  ( in-R ) -R ( in-R ) ]  
U = A B B A 
i {£ in ( R +R ) ( 2 in-R -R ) ]  
A B A B 
whe re R i s  the numb e r  o f  r esponses on t r eatment A and R is 
A a 
t he numb e r  o f  r esponses on treatmen t B .  U has a chi  
... 
d i s t r ibut ion with 1 df . T r i a l  termination s hould be 
cons id e r ed when U > z • Use o f  the Yates cont inu ity 
i c 
co r r ec t ion o r  the F i s he r -I rwin Exact test is  found to b e  less 
accu rate fo r the g roup sequen t i a l  analys is than the test 
4 3  
bas ed o n  U ( Pococ k , 1 9 7 7 ) . 
i 
Pas te rnack and Sho re ( 1 9 8 0 )  have s hown that Pocock ' s  
ad aptat ion fo r b inary data is  app rop r i ate fo r ep id emi ologic al 
d at a . Res u l ts o f  s imu lat i ons ( Pas te rnack and Sho r e ,  1 9 8 1 )  
have s hown that t he g roup s equen t i a l  method fo r 2 x 2 tab les 
is  robus t fo r mod erate va r i at ions in g roup s i ze , s t r a t i f ied 
analys is u s ing the Mante l-Haens zel  s ta t i s t ic ( w i thout the 
cont inu ity c o r r e c t ion)  and unequ al s ample s i z es . Tab l e  4 may 
be used to compu te g roup s i zes by mak ing the fol lowing 
2 2 
sub st i tu t i ons fo r if lb : 
that 
1 .  fo r a p rospec t i ve s tudy , use  
2 
p ( 1 -p) / ( p -p ) 
2 1 
whe r e  p is  the est imated p ropo r t ion o f  pat ients 
1 
w i t h  the att r ibute and the d is eas e ,  p is  the 
2 
es t imated propo r t ion o f  pat ients without 
att r ibute and with the d i s ease and p = (p +p ) / 2 ;  
1 2 
the 
2 .  f o r a ret rospec t i ve s tudy , use the s ame as above 
except p i s  the est imated p r eva lence o f  the 
1 
a t t r ibute in the d is eased popu lat ion and p is  
2 
equ a l  to ( 1 / 2 )  p { 1 +�/ [ l +p ( �1 ) ] }  whe re � is the 
1 1 
the est imated odds rat io . 
Ga i l  et a l . ( 1 9 8 1 )  have s hown , fo r the log rank tes t ,  
t he resu lts o f  s imu lat ions a r e  cons is tent with 
theo ret ical values p ropos ed by Pocock fo r the no rma l case 
when tes ts are  pe r fo rmed at inte rvals o f  equ al numb e r s  of 
deaths ( d ) . The fol lowing tes t stat i s t i c  is  computed at t imes 
t , t , • • •  , t  
d 2 d  Nd 
id id - 1 / 2  
z = ( L ( U  -P ) J I ( L P  ( 1 -p ) J 
i k=l k k k=l k k 
4 4  
i =l , • •  , N .  
)o1 t r e atment A ? 
whe r e  U = l t r eatmen t B i . P is  the p ropo rt ion o f  
k k 
pat ien ts on t reatmen t A in the t r i a l  at t ime t and known to 
id 
have su rvived fo r t ime t or long e r . 
k 
Onc e ag a in , Tab le IV 
may b e  u s ed to compu te the add i t ional numb e r  of deaths 
-2 
r equ i red b efo re eac h analys is by mu lt iplying ent r i es by S 
whe r e , und e r  H , the ha z a rd ratio is exp < el . 
a 
I t  is  expec ted f r om t hese res u l ts that the g roup 
sequen t i a l  me thod may be g en e r a l i zed fo r a wider va r i ety of 
r espons es . I n  t he fol lowing sect ion , we w i l l  examine how we ll 
the Pocock d es ign beha ves when us ing the log i s t ic reg ress ion 
mod e l . 
CHAPTER I I I . 
GROUP SEQUENTIAL METHOD 
APPLI ED TO THE LOGI STIC REGRESSION MODEL 
3 . 1  Description of the logistic regression model. 
T he log is t ic r eg ress ion mod el is  useful i f  the 
t reatmen t r espons e is d i chotomous and i f  cova r iates mu s t  be 
tak en into cons id erat ion when meas u r ing t r eatmen t effects 
( Sc hoenfeld , 1 9 8 2  and K l e inbaum et a l . , 1 9 8 2 ) . Genera lly , a 
d ic ho tomous r esponse may be defined as success ( Y=l ) o r  
fa i l u re ( Y=O > . The p robab i l i ty o f  a success g iven K 
ind epend en t va r i ab les is  mod el led by the log istic funct ion as 
-1  
P ( Y  = 1 )  = [1  + exp < -� > 1  
whe r e  � ·  = ( 1 , X ' •  • • ' X  ) is the vec to r o f  ind epend en t 1 K 
var iables and 8 = ( 8 ,8 , . . . , 8 )  i s  the vec to r o f  model 
0 1 K 
paramet e r s . The log i s tic func t ion is con t inuous and 
monoton ic a l l y  inc reas ing f rom 0 to l .  The s hape o f  the 
log i s t ic c u r ve is s igmo id with asympto tes at P=O and P=l .  
Thes e p rope r t ies suggest a wide r ange o f  appl icat ions 
in t he b io log ical and chemical sc ienc es ( As hton , 1 97 2 ) . E a r l y  
pape r s  ( Reed and Be rk son , 1 9 2 9  and Be rk son , 1 9 51 ) s howed the 
app rop r i ateness of the log istic func t ion fo r mod eling 
chemi cal p roces s es . Fu rthe r  appl icat ions have been desc r ibed 
4 5  
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in the b i omed i c a l  sc iences , p r ima r i ly in ep id emi olog i cal  
s tudies ( K l e inbaum et al . ,  1 9 8 2 )  and in dose- respons e 
analyses ( Cox , 1 9 7 0 ) . 
An ite rated t r ans fo rmat ion on P reduc es the non l inear 
func t ion to a func t ion l inear in the 8 ' s  as follows ; 
P = [ 1  + exp < -p� > 1  
-1 
P = 1 - exp < -#�> 
P/ 1 -P = exp <Bx >  
ln ( P/ 1 -P )  = Bx 
-1 
The fu nct ion ln ( P/ 1 -P )  is  commonly r e fer red �o as the 
log i t ( P ) < an abb r eviat ion fo r log i s t ic un i t )  and is  seen to 
be an express ion fo r t he log odds s ince P/ 1 -P is  the odds o f  
ob tain ing a succes s . Two s ets o f  ind epend ent va r i ables , say 
and X 
- 2  
, may b e  compared b y  t he log odds ratio ( ln OR) : 
ln OR = log i t ( P  > - log i t ( P  > = B < x  
1 2 - -1 
- X ) • 
- 2  
G i ven n obse rvat ions , y , • • •  , y  , whe re y 
1 n 
has a 
Be rnou l l i  d i s t r ibut ion g iven X ,  the p robab i l i ty o f  success 
[ P ( Y=1 ) ] f o r  t he ith r espons e is 
p = [ 1  
i 
-1 
+ ex p < -8x > 1  
- -i 
= [ ex p <8x ) 1 [ 1  
- - i  
+ 
-1 
exp < 8x ) ]  
- - i  
and the p robab i l i ty o f  a f a i l u re [ P ( Y=O ) ] f o r  the i t h  
r esponse i s  
In o rd e r  
1 - p = [ 1  + exp < 8x ) ]  
i - i 
-1 
to mak e  statistical  inferences abou t the 
e f fects of the ir.depend ent va r i ab les on the p robab i l i ty o f  a 
succes s , i t  is f i r s t  nec es s a r y  to est imate the pa ramet ers 
47 
8 ,  8 , . . . , 8 · Three p rocedures ava i lab le are  the weight ed 
0 1 K 
least squ ares  p rocedu re ( G r i z z le et al . , 1 9 6 9 ) , min imum chi-
square p roc ed u re ( As hton , 1 9 7 2 )  and the max imum l ik e l ihood 
proc ed u re . The latter p rocedu re is prefer red s ince max imum 
l i k e l i hood est imato rs  a r e  based on suffic ient s tat istic s  
( Cox , 1 9 7 0 )  and a r e  asymptot ic ally effic ient ( Rao , 1 9 7 3 ) . 
Also fo r the case we cons id er in the following s ect ion , the 
we ig hted leas t  squares  and min imum chi-square  p rocedu res are  
not appl i c ab l e  s ince the mode l  conta ins a cont inuous 
covar i at e  and the s ampl e  s i zes are relat ively smal l .  
To f ind max imum l i k e li hood es timato rs , the l i k e l ihood 
funct ion is r equ i red . The l i k elihood funct ion fo r a s equence 
o f  Be rno u l l i  va r i ables  is 
n Yl 1 -yl 
L ( P)  = TT p ( 1 -p ) , 
i=l i i 
fo r p=p , • • •  , p  , so 
1 n 
n 
L <@> = n 
y 
{ [ ex p < 8x ) ]  [ l +exp < 8x ) ] }  1 
y-1 





- -i - -i 
exp ( y  Dx ) [ l +exp < 8x > l 
i - i  - - i 
-1 
n n -1 
= exp < 7 Y .D � .
> IT [ l +exp <8x > l  t;1 1 1 i=l - - i 
The log l i k e l i hood ( LL )  i s  
n 
LL < 8> = L Y Bx 
i=l r -i - � 
log [ l +exp <8x ) ]  
- -i 
- - i  
K n n K 
x y )  - � log [ l +exp ( � = L 8 < � 
j =O j i=l ij i i=l j =O 
8 X 
j i j  
) ] 
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The max imum l ik elihood est imato rs of � • · · · • P. may be found 
0 K 
by solving the fol lowing K+l l ik el ihood equat ions 
s imultaneously ;  
[) LL (� ) / [) (3_ 0 
A closed f o rm solution does not ex ist  so a Newton-Raphson 
proced u re is used to so lve the equat ions iterat ively . 
To use  the Newton-Raphson procedure , the column vecto r 
o f  f i rst  der ivat ives of  LL with respect to � ( the score 
vecto r )  and the mat rix  o f  second der ivat ives of  LL with 
respect to must  be computed . The score vecto r is defined as 
t h  U (�) whe re  the l entry i s  
n n k k - 1  [> LL ( � ) Ib0 = L x y - .z:= x  exp L_ () x [ l +exp /: n . x . . 1 
N l i =l i l  i i=l  i l  j = O  j i j  ] = 0 1] 1 ]  
The mat r ix o f  second der ivat ives i s  defined as -I ( ) where  
I ( �) i s  F i s he r ' s  info rmat ion mat r i x ;  the refo re , the va r iance-
� -1 A 
covar iance mat r ix v < @ > is  equal to I <@ > . 
To beg in the iterat ive p rocedu re , an initial  




, i s  requ i red . The f i rst iterat ion , 
g iven by  
/" /'. A /" 
(.1 0 + V ( � ) 0 ( (3 > . 
1::.1 - o -o �o 
The i th iterat ion is g iven by 
-" (' (' 
{i, = � + v < (-3. > u <f3 . > .  
j;:.i -i -1 -1 -1 -1-1 A 1'.. 
estimate 
then is 
The iterat ive procedu re s tops when 1 � .  - � . I < � ,  where  f 
�1-l -1 
is a vecto r of smal l  pos it ive numbers  ( e . g . ,  0 . 0 0 0 0 0 1 ) . Then 
4 9  
�
- is the max imum l i k e l ihood es t imato r o f  
- l  
Onc e  the max imum l ik e l ihood est imato rs have been 
ob tained , hypo thes is tes ts on the 
Suppos e  t he ind epend ent 
va r i ab le s u c h  that X 
t reatment A and 
t r eatment B .  To 
� =0 vs H : � � 0 . 
1 a 1 
i l  
X = 
i l  
meas u re 
= 
va r i ab l e , 
0 ind i c ates 
1 ind icates 
a t reatmen t 
' s  may 
X I is 
1 
the ith 
the i t h  
effec t ,  
b e  pe r fo rmed . 
an ind icato r 
pat ient is on 
pat ient is on 
then , test H : 
0 
Three asympto t ic hypo thes is tests ava i l ab l e  are  
whe r e  
1 .  the lik el ihood ratio tes t , 
2 .  the e f f i c i en t  sco res tes t and 
3 .  Wa ld ' s  tes t . 
F o r  the l i k e l i hood ratio tes t , the tes t st at i s t ic is  
"' 0  
(3 
,...0 ,... 
- 2  [ LL ( � ) - LL (�) 
is the max imum l i k el i hood es t imato r und e r  the nu l l  
hypothes is ( i . e .  f o r t he res t r i c ted model ) . Henc e ,  assuming 
"' 0  
n o  t r eatment e ffect <�  = 0 ) , � est imates � ,  � , • • •  , � . 1 ,.... 0 2 K 
F o r  t he e f f ic ien t  sco res tes t , i t  is only nec es s a r y  to 
compute t he max imum lik e l i hood es t imato r s  und e r  the null 
0 
hypo t hes is ( � ) . The s c o r e  s tat i s t i c  ( ag a in f o r  tes t ing � = 0 )  
- 1 
i s  g iven b y  
... o 0 ... o 
U ( � } '  V ( � )  U ( � ) 
whe re u and v a r e  the s c o r e  vecto r and the va r i ance-
cova r iance mat r ix , r espec t ively , und e r  the alte rnative 
hypothes is ( i . e .  fo r the full mode l > . 
s o  
Wa le ' s  s tat i s t ic fo r tes t ing a t r ea tment effect is  
"' 2  
" 
whe r e  Va r ( � ) i s  the 
1 
(3 1 
Va r ( n ) 
1 " 
(2 , 2 )  ent ry o f  v <e> . 
All t h r ee s tat i s t i c s  have an asympto t ic chi -squ a r e  
d i s t r ib u t ion with o n e  d eg ree o f  f r eedom . The r e f o r e  eac h  
stat i s t ic m a y  b e  compared t o  the 1 - � c r i t ical  point fo r the 
chi-squ a r e  d i s t r ibut ion . The square  root of a chi-square 
s tat is tic w i th 1 d f  , say Z , is d i s t r ibuted N ( O , l )  with 
c r i t ic a l  point at z 
l - d-! 2  
i 
F o r  the g roup sequen t i a l  method us ing the log i s t i c  
model , at t h e  i t h  tes t ,  i t  is  nec es s a r y  t o  det e rmine i f  z > 
i 
z whe r e  z i s  the upper 1 - � ' / 2  c r i t ical  point as g i ven in 
c c 
Tab l e  3 .  
3 . 2  Description of the Monte Carlo study .  
A Mont e  C a r lo s tudy i s  des igned t o  der ive a nume r ical  
solu t ion , cons id e r ed to b e  otherwise in t r ac tab l e , f rom a 
g iven mod el . The model s imu la tes a real system ( Rub instein , 
1 9 8 1 ) . I n  t h i s  pape r , the real sys tem i s  a c l i n ic a l  t r i a l , 
whe re the d ata a r e  d e fined by the log i s t i c  func t ion . Seve r a l  
mod els are d e f ined to d ete rmine t he amount of va r i at ion in 
the nume r i c al s o lu t ions ob ta ined f rom the s imu lat ions . Eac h 
s imu l a t i on r ep resents a s ingle c l i n ical t r i a l . Repeated 
ind epend en t  s imu lat ions cons titu te a Monte C a r lo s tudy . 
F o r  t h i s  Monte C a r lo study,  the mod el o f  interest is 
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the f o l l owing log i s t ic reg ress ion model : 
ln [ pi ( 1 -p) l = � + � X + � X , 0 1 l 2 2 whe r e  X i s  equ al to 0 i f  the patient is on treatment A and is  l 
equ al to l i f  the pat ien t is  on t reatment B ,  and X is a 2 
con t inuous cova r i ate . A few ex amples o f  a cont inuous 
cova r i at e  a r e  ag e ,  we ight and b lood p ressu re . The cova r iate 
is d e f i n ed as cont inous s ince the log i s t i c  r eg ress ion model 
is  equ ivalent to a M an t el-Haen z e l  tes t  i f  the ind epend en t 
var iab les a r e  a l l  d i sc rete . Pas ternack and Sho re ( 1 9 8 1 ) have 
a l r eady s hown that Pocock ' s  method is  app rop r i ate fo r the 
Mante l-Haen z e l  tes t .  An interact ion term is  not inc luded in 
the mod e l  s ince tes t ing H = r  =0 would no 
0 l long e r  be 
mean ing ful . 
A r ang e 
we r e  c ompu ted . 
and X =0 . So 
2 
O f  ValUeS fo r the t rue parame t e r S  r 1 (.l and � 
0 1 -l 2 
The intercept , � , is  the ln odds when X =0 
0 l 
(3 = ln [ p I < 1 -p > 1 0 A A 
whe r e  p 
A 
i s  the p robab i l i ty o f  success fo r an ind ividual on 
t reatment A with cova r iate valu e of 0 .  � was compu ted fo r p 0 
= . 4 ,  . 6  and . 8 .  The ln odds ratio fo r compar ing treatmen t A 
to t r eatment B i s  � 
1 
r eg a rd l ess o f  the values o f  the 
cova r iate . This follows s ince 
ln [ P  1 < 1 -P > l  
A A 
and the r e f o r e , 
whe r e  p is  the 
B 
= � + � X and ln [ P I ( 1 -P ) l = p + � + � X  , 0 2 2 B B 0 l 2 2 
ln [ P < 1 -P ) I P < 1 -P > l = (3 ' 
A B B A l 
p robab i l i ty o f  success on t r eatment 




g iven in 
B .  � was 
l 
Tab le 9 .  No te p is 
A 
5 2  
chos en to b e  g r eater than p with no loss o f  gene r a l i ty . 
B 
An ac c eptab l e  range fo r r is obtained by as sumi ng 
2 
that X a f f e c ts the p robab l i ty o f  a success [ P ( Y=l ) ] and then 
2 
c ompu t ing � f o r va r i ous p a i r s  o f  va l u es ( x  and p ) , w i t h  





as spec i f i ed ab ove . 
A t o t a l  o f  3 6  models a r e  d e f i ned fo r the Monte C a r lo 
s tud i e s  and a r e  g i ven in Tab l e  1 0 . Of the 3 6  models , 2 4  
r ep re s en t  t h e  nonnu l l  c as e ,  � � 0  ( models · 1 - 2 4 )  and 1 2  
1 
r ep re s en t  the nu l l  c as e ,  � = 0  ( models 2 5 -3 6 )  . 
1 
The pu rpo s e  o f  t h i s  s tu d y  is to determine i f  Pocock ' s  
bound a r i es a r e  app rop r iate when pe r fo rmi ng hypothes is tes ts 
fo r the l o g i s t ic reg r e s s ion mod e l . The r e fo re , as requ i r ed fo r 
a g roup s eq u en t i a l  d es ig n , a max imum numb e r  o f  tes ts ( N ) , an 
ove r a l l  l eve l o f  s ig n i f i c ance (� ) and powe r ( 1 - � )  mu s t  b e  
p red e t e r m in ed . F o r  t h i s  s tudy , N = 5 and d = .OS wh ich 
c o r r es pond t o  a c r i t ic a l  valu e ,  z , of  2 . 4 1 3  < Tab l e  3 ) . The 
c 
three t e s t  s ta t i s t ic s , ( the l i k el i hood rat io t e s t  s tat i s t ic , 
the s c o r e  s ta t i s t ic and Wa ld ' s  s tat i s t ic )  a r e  t hen compa r ed 
to 2 . 4 1 3  f o r  the 2-s ided test o f  H : � = 0  vs H : � � 0 . The 0 1 a 1 
g ro u p  s i z e  ( 2 n )  , fo r powe r 1 - {j = . 9 0 ,  i s  dete rmined by 
2 
4 )  
- C l -p > I < p  -p > whe r e  mu l t iplying 1 0 . 1 4  ( Tab le by p ' 
A B 
p= ( p  +p ) / 2 .  See Tab le 9 fo r va l u es o f  p and p and the i r  
A B A B 
c o r r e s pond ing g ro u p  s i zes . 
5 3  
Iab1e 9 .  G r oup s i zes fo r 1 - � = . 9 0 and f o r  va r i o u s  p and p . 
A B 
MOD ELS p p GROUP S I Z E  
A B 
1 - 4  0 . 4  0 . 3  2 3 0  
5 - 8  0 . 4  0 . 2  5 4  
9 - 1 2  0 . 6  0 . 5  2 5 0  
1 3 - 1 6  0 . 6  0 . 4  6 4  
1 7 - 2 0  0 . 8  0 . 7 1 9 0  
2 1 - 2 4  0 . 8  0 . 6 5 4  
2 5 - 2 8  0 . 4  0 . 4  2 2  
2 9 - 3 2  0 . 6  0 . 6  2 8  
3 3 - 3 6  0 . 8  0 . 8  2 6  










1 0  
1 1  
1 2  
1 3  
1 4  
1 5  
1 6  
1 7  
1 8  
1 9  
2 0  
2 1  
2 2  
2 3  
2 4  
Table 10. Monte C a r lo study mode ls . 
Non-nu l l  c ase 
� 0 rl 

































- 4  
- 2  
2 
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- 4  
- 2  
2 
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Nu l l  case ( �  =0 ) 
1 
Mod e l  
r'o 
2 5  - . 4 0 5 5  
2 6  " 
2 7  " 
2 8  " 
29 . 4 0 5 5  
3 0  " 
3 1  " 
3 2  " 
3 3  1 .  3 8 6 3  
3 4  " 
3 5  " 
3 6  " 
5 4  
r 2  












5 5  
F o r  eac h mod el , 2n obse rvat ions are  generat ed fo r eac h 
tes t up to a max imum o f  5 tests . The re are  an equ al numb e r  o f  
ob s e r vat ions o n  eac h t r eatment so x =0 f o r  i = l ,  • • •  , n  and 
il 
x =1  fo r i = n+l , • • •  , 2n .  The cont inous cova r iate , x , is  
il  i 2  
g en e r ated as a no rmal r andom va r i ate w i t h  mean 0 and va r i anc e 
1 . Wi t h  r espect to the mean and va r i anc e ,  the r e  is no loss o f  
gene r a l i ty because it is analagous t o  scal ing a g iven 





X I - X  I 
2 2 
SD ( x  1 )  
2 
G i ven x , x  and the pa rameters 
i l  i 2  
p robab l i ty o f  success ( p  ) i s  computed as 
i 
exp �x 
p = - -i 
i 1 + exp �x 
- -i 
f\ , , , p ,  
1 · o \-1 2 
the 
To generate the y 1 s ,  2n u n i fo rm va r iates < u  ) are  g ener ated 
i i 
and comp a r ed to p • I f  p > u then y =1 and , l i k ewis e ,  i f  p 
< u then y = 0 . 
i i 
i i i i i 
Emp i r ic a l  es t imates o f  � fo r  the nu l l  case ( models 2 5 -
36 ) and emp i r ic a l  es t imates o f  1-� fo r t h e  non-nu ll c a s e  
<models 1 - 2 4 )  a re computed based on 5 0 0  ind ependent 
-
s imu l at ions fo r eac h model . The M is measu red fo r the non-
null c as e .  
The p rog r am fo r c a r rying out the s imu lat ions is 
wr it ten in PROC MATRIX ( SAS) and may be found in Append ix 1 .  
3 . 3  Monte Carlo study results and discu�siQn� 
3 . 3 . 1  Parameter est imates . 
56  
As d es c r ib ed in s ec t ion 3 . 2 ,  the max imum l ik el ihood 
es t imato r s ( MLE ) of the model paramet e r s  are compu ted fo r 
eac h  t r i a l  s imu lat ion . The MLE ' s  
und e r es t imate the t ru e  paramet e r s  
o f  � 
when 
0 
� = 0 
cons is tently 
± . 4 0 5 5  by 
approx ima t e l y  8 % . The ab solut e . d i f f e r ences between the 
est imates and the t ru e  paramete rs rang ed f rom . 0 1 0  to . 1 1 6 . 
Fo r � = 1 . 3 8 6 3 , the MLE ' s  o ve r est imated the t rue paramet er by 
0 . 
approx imately 3 %  with the ab solute d i f fe rence r ang ing fr om 
. 0 0 8  to . 2 1 4 .  
The MLE ' s  fo r �
l 
ove r es t imate the t rue parame ter  
valu es b y  app rox imately 11%  fo r a t r eatmen t d i fference o f  . 1  
and by app rox ima t e ly 2 0 %  fo r a t r eatment d i fference o f  . 2 .  
The ab solute d i f f e rences r ange f r om . 0 1 5  to . 2 2 3 . 
The ab solute va lues o f  t he MLE ' s  fo r � a r e  g r eater 
2 
then the t ru e  p a r ame ters  by an ave rag e o f  6 % . The ab solute 
d if f e r en c es between the t rue and es t imated pa rameters range 
f ro m  . 0 2 2  to . 6 4 6 . 
3 . 3 . 2  Non-nu l l  case r es u l ts . 
To d et e rmine i f  the sample s i zes spec ified by Pocock 
( Tab le 4) a r e  app rop r i ate when us ing the log i s t i c  reg ress ion 
mod e l , powe r i s  est imated fo r the non-nu l l  mod els ( 1 - 2 4 > . F o r  
a l l  mod els , the est imated powe r is l e s s  then the expec ted 
theo r et ical powe r o f  . 9 0 ( s ee Tab le 1 1 > . F rom Tab l e  1 1 , the 
max imum est imated powe r is  . 8 1 4  fo r mod el 6 ( �  =- 2 )  when 
2 
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per fo rming the lik el ihood rat io tes t . The min imum est imated 
powe r is  
• 
445 for  model 1 3  ( 0 = - 4 )  • The eff ect o f  the 2 
ab solute mag n itude o f  � is read i l y  appa rent . I t  is 
2 
leg i t imate to cons id e r  
(32 
in te rms o f  its ab solute value 
s inc e i t  is  the ab so lute value wh ich r e flects the impo r tanc e  
o f  p t o  the mod el . F o r  ex ampl e ,  � = -4 and + 4  both ind icate 
2 2 
that t he cova r iate s t rong l y  influences - outcome but in 
oppos ite d i rec t ions . The ave rag e est imated powe rs fo r mod els 
w i t h  1 p  I = 4 and fo r models with I �  I = 2 are r espec t ively 
2 2 
. 5 2 1  and . 7 0 0 . I t  appea r s , then , that as the influenc e o f  the 
cova r iate on ou tc ome inc reases , the powe r dec reas es 
app rec i ab ly .  
To con f i rm that the loss o f  powe r is due to the 
add i t io n  of t he cova r iate to the model , s everal  models 
v ! tho u t  � a re s imu lated . A powe r of . 9 0 wou ld be expec ted 
2 
based on the wo rk o f  Pas te rn ack and Sho re ( 1 9 8 1 )  and Pocock 
( 1 9 7 7 ) . The ave rage est imated powe rs fo r models with p o f  
A 
. 4 ,  . 6  and . 8  a re . 9 3 ,  . 8 4 and . 7 2 ,  r espect ively . F o r  non-
null case models when per fo rming LRT , the ave rag e es timated 
powe r s  a r e  . 7 7 ( models 2 , 3 , 6  and 7 ) , . 6 9  < models 1 0 . 1 1 . 1 4 and 
1 5 )  and . 7 0 < models 1 8 , 1 9 , 2 2 · and 2 3 ) . F o r  models with p = . 4  
A 
and . 6 ,  the re is a cons id erable loss o f  powe r ( . 1 6  and . 1 5 ,  
r espect ive ly) 
interest ing 
when inc lud ing I �  1 = 2 in the mod el . I t  is 
2 
to note that the powe r when p = . 8 is  
A 
1 8 %  less 
than ex pec ted . The s imu lat ion s tud ies by Pas te rnack and Sho re 
( 1 9 8 1 ) ans Pocock ( 1 9 7 7 )  do not cont rad ict thes e results 
5 8  
s ince the i r  p ' s  ranged f r om . 3  t o  . 5 5 .  
A 
A comp a r ison o f  the results fo r the three test 
stat i s t i c s  r eve als that the est imated powe r fo r the 
lik e l i hood r a t i o  tes t ( LRT ) is always g reater than the 
e ff i c i en t  s c o r es test ( EST ) and , in tu rn , the EST is  always 
mo re powe r fu l  t han Wa ld ' s  tes t ( WT) ( Tab le 1 1 ) . F o r  models 
with I �  I = 4 ,  WT is , on the ave rage , 2 . 4 % less powe r fu l  than 
2 
the E ST and 3 . 3 % l es s  powe r fu l  than the LRT . F o r  models with 
I �  I = 2 ,  WT i s , on the ave rag e ,  1 %  less powe r fu l  than the 
2 
EST and 2 %  l es s  powe r fu l  than the LRT . The refo r e , i t  seems 
that WT b ec omes mo re c ons ervat ive compared to the LRT o r  EST 
as I �  I inc reas es . 
2 
G i ven N= S ,  powe r= . 9 0 and d- = . 0 5 ,  M ,  fo r Pocock ' s  
method , i s  2 . 8 4 .  Howeve r ,  s ince the est imated powe r is 
cons id e r ab l y  less than . 9 0 for a l l  mode ls , i t  is  expec ted 
that the numb e r  o f  tests to t r i a l  termination wou ld be 
g reat e r  t han 2 . 8 4 .  This is , ind eed , the cas e .  F o r  I �  I = 4 ,  
2 
the ave rage numb e r  o f  tests to te rminat ion r anges f rom 3 . 8 3 
to 4 . 1 5  ( Tab le 1 2 ,  LRT) • This is  cons is tent with the 
theo ret ic a l  va lue fo r the M wh ich is 4 . 0 4 ( Pocock , 1 9 7 7  Tab le 
3 ) . L i k ew i s e  fo r I �  I .  = 2 ,  the ave rag e numb e r  of tests to 
2 
terminat ion r anges f r om 3 . 1 5 to 3 . 6 5  ( Tab le 1 2 , LRT ) 
cor r espond i ng to the theo ret ical value o f  3 . 4 1 f o r  powe r o f  
• 7 5  ( Tab le 4 ) . 
F o r  a l l  models , on the ave rag e ,  WT requ i r es the 
max imum numb e r  o f  s ig n i f icance tes ts to t r ial terminat ion . 
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Howeve r , cons id er ing the s tand ard deviations , the three tes ts 
do not d i f f e r  s ig n i f i c ant ly . All three s tat is t ical tes ts 
ave r ag ed app rox imately 4 s ig n i f i c ance tes ts fo r t r i a l  
terminat ion g iven I �  1 = 4 and app rox imately 3 . 5  g iven 1 � 1 =2 . 
2 2 
3 . 3 . 3 Null case results. 
To d et e rmine i f  t he Pocock boundar ies ( z  ' s  in Tab l e 
c 
3 ) a r e  app rop r iate fo r the log i s t i c  r eg ress ion model , the 
s i ze is meas u red fo r the nu l l  models ( 2 5 - 3 6 ) . F rom Tab l e  1 3 , 
i t  appea r s  that s i ze is cons is tent with the expec ted le vel o f  
s ig n i f i c ance o f  .OS . S i ze r anges f r o m  . 0 2 8  t o  . 0 6 7 .  Ave raged 
ove r a l l  t h r ee s tat i s t i c a l  tes ts , the s i ze is  . 0 4 5 .  
The c ons e r vat iveness o f  WT i s  onc e ag a in appa rent . F o r  
a l l  models , the s i ze fo r WT is less than the s i ze fo r LRT and 
EST by app rox imately . 0 1 6  and . 0 0 9 ,  r espec t i ve ly . 
The ave rage numb e r  o f  tests to termination fo r the 
nu l l  c a s e  mod e ls is app rox imately 5 ( 4 . 9 0±. 5 1 )  as expec ted . 
3 . 4  Conclusions and suggestions for future�Ik� 
F o r  the mod e ls s imu l ated , Pocock ' s  boundary when 
pe r f o rming a max imum o f  5 tests at an ove ra l l  s ignif icanc e 
leve l  o f  . OS ( z  = 2 . 4 1 3 )  is  app rop r iate . The r i sk o f  mak ing a 
c 
typ e I e r ro r  is min ima lly changed by the add it ion o f  a 
cova r i a te to the log i s t i c  model . 
The s amp l e  s i zes g i ven in Tab le 4 a r e inad equ ate fo r 
ma intain ing a power o f  . 9 0 .  When compu t ing sample s i ze fo r a 
g iven power and max imum numb e r  o f  tests , the influence o f  a 
6 0  
cova r iate o n  outc ome mu st b e  cons id ered . F u rther s imu lat ion 
s tud i es may b e  d es igned to dete rmine the app rop r i ate sample 
s i zes for a r ang e o f � to ma intain a g iven powe r .  I t  wou ld 
2 
also b e  interest ing to meas u re the e f fect on powe r when 
mod e l l ing mo re than one cova r iate . 
I n  conc lus ion , i t  appears that Pocock ' s  g roup 
s equen t i a l  me thod c annot be g ene r a l i zed for the log i s t i � 
r eg r ess ion mod e l  b y  s imply us ing the values g i ven in Tab les 3 
and 4 w i t ho u t  cons id erab l e  loss o f  powe r .  
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Table 11. Es t imated powe r fo r the non-nu l l  case when 
per fo rming the l i k e l ihood rat io tes t ( LRT ) I the e f f i c ient 
sco res tes t ( EST) and Wa ld ' s  tes t ( WT )  based on 5 0 0  
s imu lat ions fo r eac h model . 
-- - --
I �  1 = 2 I �  1 = 4 
2 2 
Mod el LRT EST WT Mod el LRT EST WT 
2 . 7 4 2  . 7 4 2  . 7 4 2  l . 4 7 8  . 4 7 4  . 4 6 8  
3 . 7 2 8  . 7 2 8  . 7 2 0  4 . 5 2 4  . 5 2 2  . 5 1 2  
6 . 8 1 4  . 8 0 8  . 7 9 2  5 . 5 8 3  . 5 6 5  . 5 1 9  
7 . 8 1 2  . 8 0 0  . 7 8 2  8 . 6 2 8  . 6 1 0  . 56 3  
1 0  . 7 0 4  . 7 0 2  . 6 9 2  9 . 4 6 8  . 4 6 4  . 4 5 8  
l l  . 6 5 4  . 6 5 2  . 6 4 8 1 2  . 4 8 8  . 4 8 0  . 4 7 0  
1 4  . 7 1 6  . 7 0 6  . 6 9 8  1 3  . 4 9 7  . 4 87  . 4 4 5  
1 5  . 6 7 2  . 6 6 6  . 6 5 8  1 6  . 4 9 6  . 4 8 2  . 4 5 6  
1 8  . 7 0 4  . 7 0 4  . 7 0 0  1 7  . 56 8  . 57 6  . 57 2  
1 9  • 7 5 6  . 7 5 2  . 7 4 2  2 0  . 5 9 6  . 5 8 8  . 5 8 2  
2 2  . 6 5 9  . 6 5 9  . 6 3 8  21 . 5 5 8  . 5 4 8  . 5 1 4  
2 3  . 6 7 9  . 6 5 7  . 6 5 1  2 4  . 5 2 9  . 5 1 5  . 4 6 7  
MEAN . 7 2 0  . 7 1 5  . 7 0 5  . 5 3 5  . 5 26  . 5 0 2  
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Table 12. The ave rage numb e r  o f  tests unt i l  t r i a l  terminat ion 
and s tand ard d eviat ion* based on 5 0 0  s imu lat ions fo r each 
model . 
I �  1 = 2 
2 
Mod el LRT EST WT 
2 3 . 4 0 ( 1 . 4 4 )  3 . 4 0 ( 1 . 4 4 )  3 . 4 3 ( 1 . 4 2 )  
3 3 . 4 9 ( 1 . 4 5 )  3 . 5 1  ( l .  4 3 )  3 . 5 5 ( 1 . 4 2 )  
6 3 . 1 5 ( 1 . 5 0 )  3 . 2 0 ( 1 .  4 9 )  3 . 3 6 ( 1 . 4 2 )  
7 3 . 2 8 ( 1 . 4 2 )  3 . 3 1 ( 1 . 4 2 )  3 . 4 2  ( 1 . 3 7 )  
1 0  3 . 4 6 ( 1 . 4 7 )  3 . 4 7 ( 1 . 4 7 )  3 . 5 0 ( l .  4 6 )  
1 1  3 . 6 5  ( 1 . 4 5 )  3 . 6 6  ( 1 . 4 5 )  3 .  6 9 ( 1 . 4 4 )  
1 4  3 . 5 5 ( 1 . 4 7 )  3 . 5 9 ( 1 . 4 5 )  3 . 6 9  ( l .  4 0 )  
1 5  3 . 5 8 ( 1 . 4 5 )  3 . 6 3  ( 1 . 4 2 )  3 .  7 1  ( 1 . 3 8 )  
1 8  3 . 5 1 ( 1 . 4 9 )  3 . 5 2 ( 1 . 4 9 )  3 . 5 6 ( 1 . 4 8 )  
1 9  3 . 3 5  ( 1 . 4 5 )  3 . 3 6  ( 1 . 4 4 )  3 . 4 2  ( l .  4 3 )  
2 2  3 . 6 6 ( l .  4 6 )  3 . 7 2  ( 1 .  4 2 )  3 . 8 9 ( 1 . 3 0 )  
2 3  3 . 5 4 ( 1 . 3 2 )  3 . 6 3  ( 1 . 2 9 )  3 . 7 5  ( 1 . 2 9 )  
I �  1 =4 
2 
Mod e l  LRT EST WT 
1 4 . 1 4  ( l .  3 1 ) 4 . 1 6 ( l .  3 0 )  4 . 2 0  ( l .  27 ) 
4 3 . 9 0 ( 1 . 4 5 )  3 . 9 2  ( l .  4 3 )  3 . 9 6 ( l .  4 1 )  
5 3 . 9 0 ( 1 . 3 8 )  4 . 0 2 ( 1 . 3 0 )  4 . 1 7  ( 1 . 1 6 )  
8 3 . 6 4  ( 1 . 4 7 )  3 . 7 7  ( l .  4 1 )  4 . 0 4 ( 1 . 1 9 )  
9 4 . 1 5  ( 1 . 3 3 )  4 . 1 8  ( l .  3 1 ) 4 . 2 1 ( 1 . 2 7 )  
1 2  4 . 1 2  ( 1 . 3 3 )  4 . 1 5  ( l .  3 1 )  4 . 1 6  ( 1 . 3 0 )  
1 3  4 . 0 2 ( 1 . 4 0 )  4 . 0 5 ( 1 . 3 8 )  4 . 2 6 ( 1 . 1 6 )  
1 6  3 . 9 5 ( l .  4 1 ) 4 . 0 2 ( l .  3 7 ) 4 . 1 9 ( 1 . 2 2 )  
1 7  3 . 9 7 ( l .  3 6 )  3 . 8 9 ( 1 . 3 9 )  3 . 9 2 ( 1 . 3 8 )  
2 0  3 . 8 3 ( 1 . 4 2 )  3 . 86 ( 1 . 4 0 )  3 . 9 0  ( 1 . 3 7 )  
2 1  3 . 9 0 ( 1 .  4 2 )  4 . 0 3  ( l .  3 1 ) 4 . 2 4 ( 1 . 1 1 )  
2 4  3 . 9 3 ( l .  3 6 ) 3 . 9 9  ( 1 . 3 3 )  4 . 2 4 ( 1 . 1 1 )  
* Stand ard deviat ion in parenthes es . 
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Table 13. Es t imated s i ze fo r the null case when pe r fo rming 
the l i k e l i hood ratio  tes t { LRT ) , the effic ient scores tes t 
( EST) and Wa ld ' s  tes t { WT )  based on 5 0 0  s imu lat ions fo r eac h  
mode l .  
Model LRT EST WT 
2 7  . 0 6 7  . 0 5 9  . 0 4 2  
2 8 *  . 0 3 9  . 0 4 1  . 0 2 8  
2 9  . 0 4 0  . 0 3 1  . 0 3 0  
3 0  . 0 5 1 . 0 4 5  . 0 3 5  
3 1  . 0 6 5  . 0 5 6  . 0 3 9  
3 2 *  . 0 3 7  . 0 2 4  . 0 3 9  
3 3  . 0 5 8  . 0 4 9  . 0 3 1  
3 4  . 0 5 6  . 0 4 3  . 0 3 5  
3 5  . 0 7 1  . 0 6 5  . 0 5 3  
3 6  . 0 4 8  . 0 4 8  . 0 4 8  
MEAN . 0 5 3  . 0 4 6  . 0 3 7  
* Bas ed o n  3 5 0  s imu lat ions . 
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T = TE S f# 2 *0 ; 
** 11\ : U N T C A L T R I AL "  ST A RTS H E;:E ;  
*** t'IE IGnTED LEA ST S QU A RES F.ST I '� ATES FO R I N I T I A L VAL UES ; 
IT =  I t T ;  P = X :.? C TT , > c  
P = D ES i mH S  I G N <  I NT C P #/ .  44 l J +J < T , I ,  2 ) + ( 3* X I <  IT, J J l ' ;  
S S I Z ES = P C , + J ; I I  = LOC C SS I Z ES l t SS I ZES = S5 I Z ES < I I . > ;  
P = P* Y < IT. > ; P = P < I I , > ; 
P = P #/S S I ZE S  t NP = N ROW < P  l ;  
r)o I = I TO N P ;  
I F  P < I , I J < =  0 THEN P ( 1  • I J = .  5#/ C M  AX < S S  I Z E S  < I , I J // 5 > > ; 
I F  P < T ,  I } > = I THEN P C  I .  I >= I - < . 5 # / ( � A X < S S I Z ES < I , l J // 5  } } ) ; 
E rn :  
F = LOG < P #  / ( I  - P  } ) ; 
SS = < S S I ZF. S #P if < I - P ) ) ; Z....F M  = ZZ_F M < I I . l ;  
·�L S E  = ! N V < l_ FM ' * r1 I A G <  SS J • Z_Fl� l * Z_ F M ' * D I AG < SS l * F ;  
* ** 'J E I'HO N- R t.. P'-!S O N  I TE R  AT Ul N P PO C ;:JT� E ; 
9 ET  A = rnS E ; 
X P Y  = X C I : T . l ' * Y C I : T . J ;  
FL AG = '"l ;  
I IT � A T::: = O; 
E PS I = 0 . ()() 1 ; 
EPS :2 = 0 .  0 I * EPS I ; 
� o W '-! I L E C FLA G = ') l ; 
I TE R ATE = I T ERATE + I ;  
I F  1.4 \X C A BS C -X C I : T , l * BET A. l l  > 1 7A .-5 7 3  Li P./ DO : 
c = c + I ; 
S = S + I ;  
I F  5 = 5 00 TH EN DO ; 
CHECK = 3 ; B ET AS U M = 0/0/') ; 
S = S - I ; 
GOTO F I N I S� ;  
E�/ 0 ; 
no TO 8 EG I N t  
E �-1 0 ; 
I =  ( J ( T , I , I ) + E X P C - X C I : T , l*R ETA l l ##- 1 ; 
U = X P Y - < X < I  : T , > ' * I > :  
I =  I # C J <T . I , I > - I > :  
I = :< C I : T • )-' * < I "� : X C I : T , > ) ; 
OELTA = S O LV E f ( {  #/T l , < U #/T l l ;  
I F  � S O C A. R S C DE LTA l # C C A BS C B ET A l +J < J , I , E P S I J ) ##- 1  ) ) < F P S 2 THE t� FLAG = I ;  
B ET A = B ET A  + DE LTA ;  
� 'JD ; 
BE TA S UM = R ETA + B ET AS UM ; 
V = I "JV < I ) : 
+ ++ W E i r;H TED L EA S T  S QU A R E S  ES T I '� A TE3 FOR I N I T I A L V A L U ES ; 
..,- = I : T ; ? = X 2 ( TI ,  l ; 
P = DE S I G N < S I G �H I NT C P# /. <1 4 ) ) +J < T , I , 2 J J ' ; 
S S I ZES = ? < , + ) : I I  = LO C C SS I ZES J ;  SS I ZES = S') ! ZE5 ! ! I ,  l t  
P = P * Y  C TI .  > ;  D = P ( I I ,  > ;  
P = P # /S S I Z E 5 ; N P = N qo W < P ) t 
l) O  I = I Tn �JP ; 
I F P < I , I > < = 0 T H E  1-J P < I , I ) = • 5 # / C ·� A X < S S I ZE 5 < I • I ) // 5 > > ; 
I F P < I . I l > = l TH E �! P < I , J ) = I - C . 5 #/ ( � A X C SS I ZE 3 < I , I  J //5 J J J : 5 > J  
E�l n ;  
F = L O G  C P # / ( 1 -P l > ; 
SS = C S S I Z E S #P # C I - P ) ) ;  Z_R M  = 7Z_P1U I I , > ; 
ri L  5 E RV: = a!V < l_R'A ' *] I A G < SS ) * Z_ P. M ) * l_ R�I ' + D l A G  C SS ) * F ; 
• •* � -I E W TO ti- R A P'"i S O N  I TE R A.T i r l N  P RO C �T)! l:{ F  FO R Tr-i C:: R t= f! UC F. 'I  MO DEL ; 
B ET A._ R\� = fi LS E�? � ;  
X _I") '·� = X 0 : : X 2 ; 
X P Y_ R �� = X_RM < I  : T , > � * Y < I t T , > :  
FL<\ G = 0 ;  
I T:: RATS 2 = 0 ; 
E PS I = 0 .  no t ; 
E PS 2 = O . O I * EPS I ; 
lO W H I L E  < FLA G = 0 ) ;  
I T!.: RA TE 2  = I TE R A TE 2  + I ;  
I F  "' A.X < A B S < - X_� M ( J : T , l * f3 ET A _ R '-� > >  > 1 74 . 1'\ 7.1 TH EN no ; 
C = C + l : 
S = S +  I ; 
I F  5 =5 00 Tii E N  D o ; 
CHE-':K = 3 ; R ET AS � M  = 0/0/l"l ; 
S = S - I ; 
GOTO F I N I SH ;  
E�ID ; 
Gn T()  9 E G  PJ ; 
E>I D ; 
! _ P M = U < T , I , I  > + E XP < - X_ P � ( I : T , l * B ET A_ R M J ) it# - 1 ;  
U_ '{ M  = X PY _ R 1� - ( '(_ R'H I t T ,  > � * I _ R M > : 
! _ P H = I _D !.I # U < T , I , l l - I _ R� ) ;  
I_f'I M = X_l V ( I  : T ,  > ' *  ( I _R M � :  X_ R1� ( I  : T ,  l l ;  
DtLT A  = SO L V E < ( I _ f?I U/ T l , < U_ R M #/T ) > ;  
I F  S S O C 4. B S C OE LTA ) # ( ( A R S < R ETA_ R M > + J < 2 , l  , E P S I J ) il #- 1 J l < E PS 2 THF.:N FLAG= I 
B ETA _RM = B E TA_RM + D E LT A ; 
F.Nn : 
I F  F LAG_W = 0  TH E N  D O ;  
***r'l A L D ' S  S T A T I S T I C ; 
W A L D = CC3ETA < ? , I l ##2 l # ( I # /V C 2 , 2 > > ; 
l_� AL� = S O RT < i'I AL D > ;  
I F  Z_� A L D  > 2 . 4 1  3 TH E�I DO ; 
T_ W A LJ = TE S T  + T_VI AL D ;  
T W_ SS = T rC SS + < TEST ##2 ) ;  
FL AG_r'l = I ; 
E W H  
�L S E  I F  TES T = 5 fH EN P_W ALD = P_� � LJ + I ;  
E N :> ;  
I F  FL AG_ L R  = 0 TH EN DO ; 
* **L I KE L I H noD qA T W  T E S T :  
9 _ LL = 8 ET A. :  XX= X ;  L PI K  UlGL I K E ;  LL FM = LL:  
B_ LL = BETA_ R M : X X = X _ R l,l ;  L I N K L O GL I K E :  LL_ R M  = LL : 
L R_3 TAT = - :2  II ( LL_R ),I - LL_ FM ) ;  
I F  LC3T A T  < = 0 TH C::N L R  S TAT = • I ;  Z_L P = S Q m" C V LSTAT ) ;  
-
I F z._ L R > :? • 4 I 3 TH E N  DO ; 
T_ L R  = TEST + T_L R ;  
TL R_ SS = TL R_ SS + C TEST U2 > ;  
Fl.. AG_L R = I ;  
E tlJ : 
F LS E  I F  TEST = 5 T� EN P_L R = P _L R  + 1 :  
END : 
I F  FLAG_ SS = n THEN DO ; 
* **S CO RE S TAT I ST I C ;  
I?FJ :  
B_S = R ETA _ R I,I  ( I  • I ) // 1) // B ET A_RM ( ? . I  > f 
I_S = ( J C T  • I • I ) + E XP ( - X  ( J  t T • l * B_S ) )  ## - I ; 
U_S = X D Y - c X r ! : T , > ' * f _S l :  
I _ S  = I _S# C J C T , I , I > - I _S > :  
I _s = X < I : T • > ' * ( I _  S � : X c I : T • > > ; 
scn q E_S T = u_s , * r N v  n _s > * u_s ; 
l_ SS = S O RT C S CO >? E_ S T l ;  
I F  Z_ SS > '2 .  4 1  3 THEN rx> :  
T_ '35 = TEST + T_ SS : 
T SS _ SS = T S S _ SS + < TE S T M # 2 ) t  
F LN1_SS = I ;  
EW:lt 
ELS E I F  TEST = 5 TH EN P _ SS = P_ SS + 1 :  
CHE CK = FLAG_W + FLAr._ L R  + F LAG_ SS : 
F I NI S H t  I F  < T FST = 5 > O R  C CHFCK = 3 )  THEN DO:  
S = S + l  t 
A VG_J:l ETA = R ETAS U M  # / TE S T ;  
S UM B E TA = S UM B ETA + AVG_B ET A ; 
I F  S =5 no TH E N  T)O ;  
NOTE R E S l f LTS FO R W A. LD STAT I S T I C ;  
·� _WA L D  = C T_W ALTJ + < 5  * P_W AL fl l >  # /  < 5 m-C > ;  
S JW= S � R T < U TW _SS + ( 2 5 # P  -'� A L!) ) l - ( ( 5 00- C l #  C A S N_I'I A L D ·'* # 2  l > ) #  I C  4 99-C > ) ; 
·� 2_tl = C T_WA L !J >  # /  < 5 00- P_� AL D-t: l : 
3 0 W:? = S J R T <  C Tri_S S - C  c 5 1l() -P_r'4 A L D-':: l f U A S N2_1'1 ##2 > > ) #/ c 4 99-P_�I A L I)-C > > :  
?CH 'IE R_ �4 = I - C P_ W ALD #/ ( 5 0J- C l l t 
p q i NT 1,\_:·I .A. L D 5 D W M2_1'1 5 ;1 1'12 P m� E R_W ; 
'Jn"'"F '7 ESl '!.. TS �o o L T KEL I '-1 ' '1 1 [)  'J A.: I ' l ST A T I ST I C ; 
\I _ U  = C T_L R + ( 5 * P_L R l l # / ( 5 00- C l ; 
S TlL =  SO R T < C C TL P._ SS + C 2 5 1f P _ L R ) l - C C 5 m- C l # C A Sn_L P. 'f# ? l l ) # / (  4 99-C l ) ;  
M 2_ L R =  C T_LR ) #/ C 5 no- P_L R-C > ;  
S !:1L 2  = S O RT ( CTLO_ SS - ( < 5 00- P _L R-C ) # (  A S 'P_L R ## 2 ) ) )  #I ( 4  99-P _L ;::t- C l ) ;  
PfWI E q_L rt = 1 - C P_L R # / C 5 1Y1- C ) ) ;  
P R HI T  'A_L R S� L � 2_LR S D L 2  P O W E R_L R ; 
�JOT E  R E S U LTS FO R S CO RE ST A T I S T I C ; 
M _SS = C T _ SS + < 5  * P_.SS ) )  !t / ( 5 rn- c  ) ;  
S O S =  S .J R T  ( ( r TSS_ SS + ( 2 5 # P  _ SS l > - ( ( 5 00-C l t H A SN_ ss •ut 2 l l l # /  ( 4 99 -C l l ;  
M 2_ S S  = < T_S S ) # /  C 5 QO- P_ SS-C ) ;  
Sf1S2 = S O RT <  C TSS _ SS - C ( 5 nn-P_ S5-C ) # (  A S �I? _ SS *#2 ) )  l * / C  � 99- D _ S S - C  l ) ; 
P O i ' C R_SS = 1 - r P _SS #/ C 5 08- C l l ;  
P '? I "JT I.(_S S S DS M 2 _  SS S DS 2  P.OW F R_SS ; 
L A. ST 8 ET A.  = S U ,� BE T A  # /  ! 5 1)0-C l ;  
l i F_ S ET .\ = 8 '  - L A STB ET A ; 
'!OTE C"l M P A R E  ·� 'l f1FL P A C>A MET F RS Tn FS T P� A TF.S ; 
�R I NT g L A ST8 ETA D I F_ B �T A ; 
\fnTE �I l JM B E �  ;1F I T E R AT I V E P ROC EDURES TH AT 0 I D  "lOT CO NV E RG E ;  
p q pfT � ;  
S T O P t  
EN IJ ;  
ELS E �OTO BEr, I N ; 
EW'lt  
ELS E � l TC> ST ART t 
�** S l 'A pnUT I NE !fl C OM P t rT E  TH E L I  KEL H mo ; 
J lGL IK:: : 
LL = Y C 1 : T . > '  * c v x c t : T . > * B_LL > - S !JM ( lC)I"; ( J ( T . 1 , 1 l + E X P C Y'< ( J : T , l * 8 _ LL l » ; 
?ET' I Ptr : 
7 7  
V I TA 
